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The plasma membrane plays a critical role in many cellular activities 
and has been implicated as the primary site for the regulation of cellular 
growth, division, development, communication, differentiation, and death 
(Wallach, 1969; Holley, 1972; Sheinin, 1974; Bretscher and Raff, 1975; 
Pardee, 1975; Nicolson 1967a,b; Edelman, 1976). An understanding of the 
structural and functional relationships within the membrane, as well as 
the mechanisms that control membrane-dependent functions (e.g., ion trans­
port, phagocytosis, exocytosis, fusion, adhesion, capping) is currently 
rudimentary. 
The analysis of relationships between structural and functional 
alterations that arise from changes in the chromosomal genetic material 
(DNA) has provided a useful way to achieve an understanding of many bio­
logical mechanisms (Debatisse and Buttin, 1977; Baker et al. , 1974; Wahl 
et al., 1975). For this reason, the purpose of this investigation was to 
isolate a class of mammalian cell mutants vitro that would contain 
specific genetic alterations affecting both membrane-associated structure 
and related function. Membrane mutants were selected on the basis of 
resistance to the toxic effects of the local anesthetic dibucaine. 
Dibucaine was used as the selective agent in this study because it 
belongs to a class of membrane active drugs that have been shown to affect 
several membrane-dependent functions in mammalian cells. For example, 
local anesthetics (e.g., dibucaine, procaine, tetracaine, benzocaine) 
inhibit cell spreading, adhesion, fusion, capping, phagocytosis, exocyto­
sis, and ion transport (Rabinovitch and DeStefano, 1975, 1976; Poste and 
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Reeve, 1972; Allison and Davies, 1974; Ryan et al., 1974; Strichartz, 
1975). Although the nature of the anesthetic-binding site and molecular 
mechanisms associated with anesthetic-induced alterations in membrane 
phenomena are unclear, these anesthetic-induced effects have been 
attributed to the disordering and fluidizing effects on membrane lipids 
(Seeman, 1972); to the direct structural alteration of a membrane protein 
(Ueda et al., 1976); to the displacement of membrane-bound calciun 
(Blaustein and Goldman, 1966a); or to the disruption of the membrane-
associated cytoskeletal system (Nicolson et al., 1976). 
Because dibucaine enters into the plasma membrane and presumably 
exerts its effect at that level, the isolation and characterization of 
variants resistant to the cytotoxic action of dibucaine might reveal an 
altered membrane component with either a reduced ability to bind the drug, 
an altered response to bound drug, or a reduced number of membrane binding 
sites for the drug. Hence, local anesthetic action can be explored more 
fully at the cellular level. 
In the experimental induction of mutant mammalian phenotypes, the 
use of tissue-derived somatic cell lines offers several advantages over 
experiments with the whole mammal. The permanent cell line has a short 
generation time, usually 10 to 24 hours, and rapidly grows to a high 
density of uniform cellular progeny. The presence of a large cell popula­
tion can increase the probability of isolating a rare mutational event. 
Conversely, the intact mammal has a comparatively longer generation time, 
a smaller number of progeny and, in most cases, a complicated expression 
of the overall cellular phenotype due to differentiated functions of 
various tissues. 
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One disadvantage in genetic studies with somatic cell lines, however, 
is that changes in chromosome number (Todaro and Green, 1963) and extensive 
chromosome rearrangements (Worton et al., 1977) occur during transformation 
of the cells from expiants of mammalian tissue to cultured cells with 
infinite reproductive capability (Hayflick and Moorhead, 1961). There­
fore, the karyotypes of vivo cells and permanent cells derived from the 
same origin are not identical; it is widely presumed that gene regulatory 
patterns in these two cell types are similar. 
The mouse lymphoid cell line L5178Y (Fischer, 1958) was chosen for 
this study because it has gene markers for cell hybridization studies, 
favorable karyotypic characteristics (i.e., chromosome stability and 
pseudodiploidy), and growth properties convenient for experimentation 
(e.g., cultivation in liquid suspension). Moreover, several researchers 
have demonstrated that mutants are easily obtained in this cell line 
(Clive et al., 1972; Cole and Arlett, 1976). In the present investigation 
a number of dibucaine-resistant (Dib^) clones from L5178Y cells were 
isolated after treatment with the mutagen ethyl methane sulfonate and 
a single-step selection procedure. Also, evidence is presented that 
suggests that the dibucaine-resistant phenotype may result from a true 
alteration at the DNA level. Subsequent experiments attempted broader 
physiological characterization of the variants. Future approaches to 
biochemical studies of this class of variant cells are suggested, 
A discussion of membrane structure, physical-chemical properties of 
local anesthetics, and the theories that attempt to explain the effects 
of local anesthetics on cells is essential for a further understanding 
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of the possible factors involved in the acquisition of resistance to 
dibucaine. In addition, the essential features of the induction and 
isolation of somatic cell mutants will be reviewed. 
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REVIEW OF LITERATURE 
Mutation in Cultured Mammalian Cells 
Experimental mutagenesis using mammalian cells is an important tech­
nical development in somatic cell genetics because it increases the fre­
quency of heritable variation in cell populations. Genetic and bio­
chemical characterizations of these genetically altered cells have greatly 
facilitated an understanding of the regulation and the sequence of molecular 
events that underlie many cellular functions. Somatic cell mutants in 
vitro have been shown to be altered in their sensitivity and resistance 
to various external agents, their growth requirements, their expression of 
specialized cellular functions, or their expression of transformed growth 
characteristics. 
The diploid nature of somatic cells would seem to favor the isolation 
of codominant or dominant mutations, i.e., expressed in autosomal genes 
when only one allele is altered, but would seem to present a major barrier 
in the isolation of recessive mutations because both alleles in an auto­
somal gene would have to be altered for phenotypic expression. Neverthe­
less , a great majority of the mutants that have been isolated behave 
recessively when tested in somatic cell hybrids. Available evidence 
indicates that cells in culture, particularly Chinese hamster ovary (CHO) 
cells are heterozygous or hemizygous at several gene loci (Siminovitch, 
1976), thus facilitating the retrieval of recessive mutations. 
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Criteria for the classification of 
phenotypic variants as mutants 
Heritable variation in phenotype could be the result of either a 
gene mutation or an epigenetic event. Mutational events are conventionally 
defined as heritable qualitative or quantitative changes in the chromo­
somal genetic material (DNA)• These alterations include nucleotide base 
substitutions (point mutations) or deletions in the DNA base sequence. 
In addition, the loss, gain, or rearrangement of chromosomes are con­
sidered mutational events (DeMars, 1974; Siminovitch, 1975). Epigenetic 
variation is broadly defined as those forms of inheritance that do not 
involve changes in the DNA structure. The molecular basis of epigenetic 
events is obscure. There has been little documentation that epigenetic 
modulation is a major complication in the isolation of mammalian cell 
mutants despite an active discussion of an epigenetic basis for variant 
phenotypes (Terzi, 1974; Harris, 1971; Mezger-Freed, 1971; Siminovitch, 
1976; DeMars, 1974). 
Several criteria can be applied to assess the mutational origin of 
a variant phenotype (Thompson and Baker, 1973). A variant cell is con­
sidered to be the result of a gene mutation when an altered phenotype is 
stably transmitted through many successive generations of cells in the 
absence of the selective agent. Phenotypic variants that are the result 
of a point mutation may revert to the parental phenotype, but at a very 
low frequency. The reversion frequency can be augmented by mutagenic 
treatment because, in this case, reversion is usually the consequence of 
a back mutation at the altered locus or a suppressor mutation elsewhere in 
the genome (Kao and Puck, 1968; Chasin, 1973). 
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Also, in "true" mutants the spontaneous mutation rate responsible 
for the observed phenotype is enhanced by mutagen treatment (Chu and 
Mailing, 1968). Several investigators have shown that the induced-
mutation frequency to drug resistance in mammalian cells increased pro­
portionally with increasing mutagen concentration at a fixed treatment 
time (Friedrich and Coffino, 1977; Hsie et al., 1975; Penman and Thilly, 
1976). 
The association of an altered phenotype with changes in the activity 
and physicochemical property of a specific gene product, such as an 
altered protein, is the most persuasive evidence that phenotypic varia­
tion results from a mutated gene (Albrecht et al., 1972; Chan et al., 
1972; Beaudet et al., 1973). Furthermore, designation of a specific 
region of the chromosome as the location of the altered gene, which is 
responsible for the variant phenotype, provides unequivocal evidence that 
the variant cell is the "true" mutant. This is rarely accomplished with 
somatic cells because the absence of sexual reproduction and meiotic 
exchange makes cultured cells inadequate systems for recombinational 
mapping. Nevertheless, cell hybridization techniques have been used to 
map a number of genes in mammalian cell lines (Ruddle and Creagan, 1975). 
Most investigators designate variant cells as mutants when a stable 
phenotype is demonstrated, whereas, some consider the presence of an 
altered gene product, response to mutagens, and fulfillment of other cri­
teria as conclusive evidence that the variant phenotype is genetically 
based. In this review, the term will be used in the broad sense, based 
only on phenotypic stability. However, the drug-resistant isolates 
8 
obtained in this study will be referred to as variants because the term 
mutant will be used in the strict sense to indicate the presence of an 
altered gene product. 
Characteristics of mammalian cell lines 
important for mutant isolation 
A significant aspect in the development of somatic cell genetics was 
the observation that cells derived from animal tissue could be grown with 
relative ease in culture (Carrel, 1912; Sanford et al., 1948; Puck and 
Marcus, 1955; Eagle, 1955). Although primary cells from tissue expiants 
offer the most "normal" genetic constitution, they are not appropriate 
for selecting mutants because cell death occurs after several generations 
(Hayflick and Morrhead, 1961). Transformation of primary cells with 
limited growth ability to cells with infinite growth ability can occur 
spontaneously or by induction with certain chemical or viral agents 
(Puck, 1958; Tasne et al., 1974; Freeman, 1973; Girard, 1965). Also, 
transformed cell lines can be derived directly from animal tumors (Sato 
et al., 1957). Cells with infinite growth ability are commonly called 
established or permanent cells. 
During the process of transformation from primary cells derived from 
animal tissue to permanent cells, extensive chromosome rearrangement, 
changes in the basic chromosome number, and chromosomal instability are 
observed (Todaro and Green, 1963; Norton et al., 1977). Nevertheless, 
permanent cells cultivated vitro maintain their cell structures and 
characteristic morphology. Also, they continue to express "household" 
functions (e.g., involve in general macromolecular synthesis, cell cycle, 
and metabolism), which are essential for cell survival, and a number of 
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tissue-specific genes coding for "luxury" functions (e.g., the synthesis 
of antibodies, melanin), which are not required for cell survival but 
are critical to the viability of the intact mammal (Ephrussi, 1972). 
Consideration of karyotype Permanent cell lines differ consider­
ably in the extent of their aneuploidy; some cell lines are hyperploid 
and thus exhibit excessive numbers of chromosomes, e.g., HeLa cells and 
mouse L cells and other cell lines have an approximate diploid number of 
chromosomes (quasi or pseudo-diploid), e.g., Chinese hamster ovary cells. 
Cell mutants have been obtained from both pseudodiploid and hyperdiploid 
cells (for references see Thompson and Baker, 1973). The pseydodiploid 
cell lines with relatively stable chromosome constitutions often are 
chosen for the isolation of mutants (Thompson, 1979; Baker and Ling, 
1978). Chromosome stability minimizes the chances for phenotypic 
variation that is the result of chromosomal changes. 
Consideration of cell growth Because the isolation and 
characterization of somatic cell mutants is frequently a lengthy procedure, 
it is best to choose a cell line with a short population doubling time. 
High plating efficiency, which measures the ability of a single cell to 
yield a colony, is another important quality because cell mutants can be 
isolated only after they have formed visible colonies. Also, plating 
efficiency has become an accurate measurement for characterizing the 
ability of physical, chemical, or biological agents to modify cell growth. 
Some established cells grow in liquid suspension (e.g., cells of 
lymphoid origin); whereas, other established cells adhere to the surface 
of a culture vessel and grow in a monolayer (e.g., epitheloid or fibro-
blast-like cells). The method of cultivation may be an important 
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consideration, depending on the nature of the mutation to be isolated. 
For instance, cultivation in monolayer will select against poorly adhering 
cells to some extent because they may detach and consequently may be dis­
carded during subculturing. But if one wanted to isolate cells with 
altered adhesive properties, the obvious choice would be a cell line that 
adhered to a substratum to grow (Pouysseegur and Pastan, 1976). 
Cell hybridization 
Cell hybridization is useful for studies of gene interaction, 
expression, complementation, recombination, segregation, and mapping. 
This technique depends on both the success of cell fusion between parental 
cells of the same line (intralineal cross) or two different species 
(interspecific cross) and the identification of gene markers from each 
parent (for review see Chu and Powell, 1977). Hence, it is advantageous 
to use a cell line for the isolation of mutants that is both fusion 
competent and identifiable by gene markers. 
Induced mutagenesis 
Although mutational events occur spontaneously at a very low level, 
addition of a mutagenic agent is sometimes necessary to increase the 
mutation frequency to a detectable level using a reasonable number of 
cells- For example, the frequency of 8-azaguanine resistant clones from 
V79 Chinese hamster cells was reported to be enhanced 10 to 100 fold by 
treatment with different mutagenic agents (Chu and Mailing, 1968; Bridges 
et al., 1970). 
Both physical agents (e.g., X-irradiation, ultraviolet [UV] rays) 
and chemical agents (e.g., ethyl methane sulfonate, EMS; 
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N-methyl-N'-nitro-N'-nitrosoguanidine, MNNG; ICR compounds; 5-brcmode-
oxyuridine) have been shown to induce mutations in mammalian cells (for 
review see Thompson and Baker, 1973). The most commonly used mutagens are 
the alkalating agents, MNNG and EMS. These agents act as mutagens in 
microorganisms by alkalating DNA bases and thereby producing primarily 
transitional types of point mutations (Drake, 1976; Lawley, 1974). EMS 
has been the most popular choice and has proved efficacious for augmenting 
mutation frequencies at a variety of gene loci (Till et al., 1973; Baker 
et al., 1974; Friedrich and Coffino, 1977). Although MNNG has been shown 
to be an effective mutagen in mammalian cells, it is more cytotoxic than 
EMS. 
Studies with various mutagens (e.g./ EMS, MNNG, ICR compounds. X-rays) 
have demonstrated a mutagen specificity (Clive et al., 1972; Arlett et al., 
1975; Cole and Arlett, 1976; Friedrich and Coffino, 1977). Friedrich and 
Coffino (1977), for example, observed that ICR 191, predominantly a frame-
shift mutagen in bacteria (Ames and Whitfield, 1966), failed to induce 
ouabain resistance in mouse lymphoma cells; whereas, MNNG readily 
generated ouabain resistance. Treatment of these cells with ICR 191, 
however, resulted in substantially more 6-thioguanine (6TG) resistant 
clones than treatment with MNNG. 
The acquisition of ouabain resistance is apparently the result of an 
"f" 
altered Na /K -activated ATPase, an essential membrane enzyme (Baker et 
al., 1974). Because ICR 191 may cause frameshift or deletion mutations in 
animal cells, Friedrich and Coffino (1977) speculated that this mutagen 
led to a complete loss of Na /K -activated ATPase activity, which in turn 
caused cell death. MNNG, a successful mutagen for the induction of 
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ouabain resistance, seems to induce missense mutations that resulted in a 
structural alteration which rendered the enzyme only partially nonfunc­
tional and therefore nonlethal. Cells resistant to 6TG, however, are 
defective in hypoxanthine-guanine phosphoribosyltransferase, a non­
essential enzyme under normal culture conditions (Arlett et al-, 1975). 
Complete loss of its activity would not affect cell viability and thus 
6TG resistant clones can be produced by either a missense inducing 
mutagen or a frameshift inducing mutagen. Therefore, the differing 
abilities of various mutagens to induce a particular variant phenotype 
may reflect the nature of the alteration in the DNA base sequence and 
gene product. 
Mutagen concentration and treatment time An essential step in 
experimental mutagenesis is the determination of single cell survival as 
affected by mutagen treatment. This is established by plating cells in 
the presence of increasing concentrations of a mutagen and determining the 
percentage of resultant cell colonies. Most investigators use mutagen 
doses that result in a 70% to 90% cell lethality (Thompson, 1979; 
Basilico, 1977). Because variability is observed in the percentage of 
cell survival induced with the same mutagen dose, it is important to 
determine the lethal effect of a particular mutagen dose in each experi­
mental trial (Shapiro and Varshaver, 1977; Cole and Arlett, 1976). In 
addition, because different cell lines and different cell strains derived 
from the same cell line are known to exhibit different sensitivities to 
mutagen treatment, a dose response for a particular mutagen must be 
established for each cell type (Thompson and Baker, 1973). 
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A high mutation frequency is usually associated with a high percentage 
of cell killing induced by the mutagen (Friedrich and Coffino, 1977; 
Penman and Thilly, 1976; Hsie et al., 1975). The significance of this 
relationship is unclear. Hsie and coworkers (1975) found that the 
dose-dependent mutagenicity of EMS in CHO cells was a simple log-linear 
relationship. However, the shape of the corresponding cell survival curve 
included an initial shoulder at low mutagen doses followed by a straight 
segment at high mutagen doses. They suggested that the difference in the 
shapes of the cell survival curve and the curve for EMS-induced mutation 
indicated that mutagen toxicity may be the result of a different mechanism 
than induced-gene mutation in mammalian cells. This notion is plausible 
because EMS toxicity in bacteriophage seems to result from depurination, 
while EMS apparently acts as a mutagen by ethylating DNA bases, thereby 
triggering mispairing (Kreig, 1963). 
Most investigators use a cell density for mutagen treatment in which 
the cells are still in logarithmic growth and the total number of cells is 
sufficiently high to ensure a detectable level of mutants after mutagenesis. 
Mutagen treatment times differ among the various mutagens. For example, 
cells usually are exposed to EMS for a period slightly longer than one cell 
population doubling time (Hsie et al., 1975; Friedrich and Coffino, 1977; 
Kao and Puck, 1969; Thompson, 1979). In contrast, cells treated with MNNG, 
which acts quickly, usually are exposed for a short time interval, 
usually less than one population doubling time (Basilico and Meiss, 1975). 
Fixation and expression of mutations Several investigators have 
gathered information about the kinetics of mutation induction (Hsie 
et al., 1975; Friedrich and Coffino, 1977; Penman and Thilly, 1976; 
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Cole and Arlett, 1976). Their data have shown that the time interval 
between mutagen treatment and cell transfer to selective conditions deter­
mines the number of retrieved somatic cell mutants. This time period is 
commonly referred to as fixation, expression, or phenotypic lag. For 
example, Cole and Arlett (1976) found that a maximal number of ouabain 
resistant clones in mouse lymphoma cells appeared immediately after EMS 
treatment. In contrast, the greatest number of lymphoma cells resistant 
to 6-thioguanine did not occur until 6 to 8 days after mutagen treatment 
and the highest frequency of thymidine resistant cells was observed at 
2 to 4 days. Cole and Arlett (1976) and several other investigators 
(Shapiro et al., 1970, Duncan and Brookes, 1973; Arlett and Harcourt, 1972) 
have reported that after the maximal-mutant frequency was obtained, the 
number of detected mutants decreased. These authors suggested that an 
excessively long mutation expression period may result in a selective 
disadvantage for mutant cells if their growth rate is less than the wild 
type cells. 
It has been hypothesized that this growth interval allows for the 
fixation and expression of mutations. One can envisage necessary rounds 
of DNA replication permitting the completion of base transitions and 
segregations. Alternatively, time may be required for events (e.g., 
somatic recombination and chromosomal rearrangements) that are essential 
for obtaining recessive mutations in a homozygous or hemizygous state. 
Also, a certain number of cell divisions may be necessary for the dilution 
of pre-existent gene products so that induced mutations may be expressed 
phenotypically (Cole and Arlett, 1976). 
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Selection of membrane mutants of 
cultured mammalian cells 
After mutagenesis, a selection scheme is devised to facilitate the 
isolation of rare induced mutants arising in a large cell population. In 
the following sections, several experimental strategies will be discussed. 
Although these techniques have been used to isolate a variety of cell 
mutants ^  vitro, examples of methodologies in this review will be limited 
to reports on the isolation of membrane mutants. 
Several mutant cells that have an alteration in their plasma 
membrane have been isolated and studied in tissue culture (for review 
see Baker and Ling, 1978). Mutations that affect the membrane fall into 
two distinct categories, mutations that result in an altered permeability 
to an agent with an intracellular target protein, and mutations that 
result in an altered response to an agent that specifically acts on a 
membrane structure. 
Isolation of drug resistant mutants; single-step selection Because 
both classes of membrane mutants usually exhibit resistance to a selective 
agent or drug, a straightforward approach to mutant isolation involves 
selective conditions favoring the direct outgrowth of drug-resistant clones 
A mass culture of cells is treated in the presence of a drug concentration 
that signiciantly reduces the plating efficiency or completely eliminates 
wild type cells. The drug-resistant mutants retain a "normal" plating 
efficiency, but not necessarily a normal growth rate, in the presence of 
the drug. This method, referred to as single-step selection, has been 
used to isolate somatic cells resistant to membrane-active drugs, e.g., 
ouabain (Baker et al., 1974) and phytohemagglutinin (Stanley et al., 1975) 
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and drug-resistant cell lines with altered permeability, e.g., resistance 
to bromodeoxyuridine (Mezger-Freed, 1972), methotrexate (Flintoff et al., 
1976), and colchicine (Till et al., 1973). These permeability-altered 
mutants were usually the result of attempts to isolate cells with altered 
intracellular components. Sometimes the membrane presents a barrier to 
direct selection because the drug must pass through the membrane via 
facilitated transport (e.g., methotrexate) or unmediated diffusion (e.g., 
colchicine). 
Selection performed in a single step is a preferred methodology be­
cause a mutant isolate will exhibit the minimum number of genetic changes 
and presumably may be a single mutation. In addition, the frequency of 
occurrence of the altered trait can be determined. 
Isolation of drug resistant mutants ; enrichment and multi-step 
selection procedures When single-step selection is met with limited 
success, either an enrichment regime or a multi-step selection can be used 
to obtain mutants. In an enrichment procedure, a mass culture of cells 
is continuously subcultured in the presence of gradually increasing drug 
concentrations until wild type cells are eliminated, or cells expressing 
a mutant phenotype occurred frequently enough to be isolated by screening 
a reasonable number of colonies. The isolation of variant cells with 
altered surface antigens exemplifies this approach (Adman and Pious, 
1970. Mutants of human fibroblasts were obtained after 6 cycles of 
a 10-fold enrichment procedure in the presence of antisera produced 
against cell surface antigens. 
One major disadvantage of the enrichment procedure is that the 
resultant variant cell population may be heterogeneous. Also, because the 
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cells are continuously exposed to the selective agent, the number of 
genetic changes associated with the variant phenotype is difficult to 
assess; cells may contain multiple genetic changes. 
A multi-step protocol, however, differs from enrichment selection in 
that it involves a sequence of discrete single-step treatments, usually 
with progressively more severe selective phases. Cells can be sampled and 
characterized at each step to monitor the number of genetic changes. 
An important aspect of a multi-step selection scheme is that this approach 
may unmask different mechanisms of drug resistance other than an incom­
petent uptake of the drug (i.e., altered permeability), such as, an altered 
affinity of the intracellular target for the drug, or an increased level 
of drug target. This is illustrated by the isolation of cells resistant 
to methotrexate. Methotrexate-resistant mutants of the first two 
mechanisms have been obtained by using a single-step selection procedure 
(Harrap et al., 1971; Flintoff et al., 1977). When Flintoff and coworkers 
(1977), however, applied a second step of selection, using mutants with 
an altered drug target (dihydrofolate reductase) as the parent cell 
line, resistant cells were obtained with elevated levels of 
dihydrofolate reductase (DHFR). Resistance in this case was correlated 
with an increase in the number of gene copies coding for the DHFR enzyme 
(Schimke et al., 1978). 
Selection for a physical characteristic other than growth Membrane 
mutants have been obtained by using selection procedures for altered physi­
cal characteristics other than growth in the presence of a chemical agent. 
The ability of cells to detach or attach to a substratum has been used as 
a selective condition for obtaining membrane mutants with altered adhesive 
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properties. For example, Atherly and coworkers (1977) selected for CHO 
cells with an altered ability to detach from the substratum by trypsin 
treatment; Klebe and coworkers (1977) enriched for CHO cells that were 
unable to adhere to collagen-coated plastic flasks; Pouysseegur and Past an 
(1976) used several cycles of selection in the presence of drugs that 
increased cell adhesion to the substratum to obtain loosely adherent mouse 
3T3 cells. 
Isolation of temperature-sensitive mutations Temperature-sensitive 
(TS) mutations have been shown to affect a cellular function that is 
essential for cell growth (e.g., DNA, RNA, or protein synthesis) or to 
result in the inhibition of a specilized cell function (e.g., myogenesis) 
at a temperature (nonpermissive) in which the parent cell line shows no 
adverse effects (for review see Basilico, 1977). At the permissive 
temperature TS mutants will grow and function but not necessarily at a 
normal rate. Although cold sensitive mutations have been isolated (Crane 
and Thomas, 1976), most of the TS mutations obtained have been heat 
sensitive; in other words, the alteration in the gene product is only 
expressed at a high temperature (nonpermissive) and not at a low tempera­
ture (permissive). Selection methods usually involve shifting a cell 
population to the nonpermissive temperature and exposing it to agents that 
are lethal for growing cells (Thompson et al., 1970) or for cells per­
forming certain functions, e.g., endocytosis (Silberstein et al., 1975). 
After selection, the population is shifted to the permissive temperature 
to allow for growth of the TS mutants. TS mutations affecting membrane-
related functions, such as myogenesis and neoplastic behavior, have been 
reported (Loomis et al., 1973; Renger and Basilico, 1973). For example. 
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Loomis and coworkers (1973) isolated a series of TS variants of a rat 
myoblast cell line that were unable to fuse into myotubes at the non-
permissive temperature (40°C). These variants were obtained by screening 
cells at 40°C in the absence of selective agents. This was a feasible 
approach because the TS mutation occurred at a very high frequency. 
Information obtained from studies of mutations 
affecting the plasma membrane 
Study of membrane-altered mutants with reduced permeability to 
compounds that enter the cell by unmediated diffusion has enabled an analy­
sis of structural and functional relationships of the cell membrane and has 
provided information about the biological significance of permeability 
changes in mammalian cells. For example, CHO cells with an altered per­
meability to colchicine are also cross resistant to a number of structur­
ally unrelated drugs (Ling and Thompson, 1974). Presumably, these drugs 
are transported by the same mechanism. Biochemical characterization of 
the plasma membranes for colchicine resistant cells shows a normal phos­
pholipid content but the appearance of a new surface glycoprotein (Ling, 
1975). An increase in the quantity of this protein on the cell surface 
was correlated with an increased resistance to colchicine. Ling and co­
workers (1977) suggested that this class of glycoproteins modulates mem­
brane fluidity by conformational changes in its structure, an ATP 
dependent process. The colchicine resistant mutants have an alteration in 
the glycoprotein that renders the cell refractory to a variety of drugs. 
Also, the study of membrane mutants may provide information about 
genetic control in the expression of malignancy in transformed cells 
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(Ozanne, 1973; Nicolson and Winkelhake, 1975). For instance, the adhesion 
of cultured cells to a substratum is an important membrane property. 
Normal cells require a surface to adhere and spread for growth, while 
neoplastic cells will grow without being attached to a substratum 
Stroker et al., 1968). When neoplastic cells, however, are cultivated in 
monolayer, they are less adhesive than normal cells (Shields and Pollack, 
1974). Studies of membrane mutants with altered adhesive properties 
indicate which cell surface components may have a role in modulating the 
strength of adhesion. For example, CHO cell mutants lacking cell surface 
hyaluronic acid adhere tenaciously to the substratum (Atherly et al., 1977) 
and mouse 3T3 variants with a decreased adhesion ability were found to 
contain a reduction in a number of cell surface polypeptides (Pouysseegur 
and Pastan, 1976). 
Additional genetic mutants with alterations in membrane components 
havs been obtained by selecting for resistance to membrane-active drugs. 
These include somatic cells resistant to ouabain, plant lectins, and con-
canavalin A (for review see Baker and Ling, 1978). CHO mutants resistant 
to ouabain seem to have an altered Nat/K^ activated ATPase (Baker et al., 
1974). It is not known if resistance to ouabain results from an altera­
tion in the ouabain-target enzyme or a less specific modification of the 
membrane. Cell mutants resistant to phytohemagglutinin have lost a 
particular glycoprotein transferase activity (Narasimhan et al., 1977), 
and cells refractory to concanavalin A are associated with altered cell 
surface glycoproteins (Gifone et al, 1977). 
Somatic cell mutants and variants resistant to local anesthetics 
Another class of membrane mutants recently isolated are cells rendered 
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resistant to local anesthetic agents (e.g., dibucaine, procaine, tetra­
caine, lidocaine). Local anesthetics presumably act at the level of the 
plasma membrane and modify cellular functions that may be regulated by the 
structural components of the membrane (Seeman, 1972). A mutant of murine 
lymphoma cells resistant to the local anesthetic procaine was selected by 
an enrichment procedure (Yau et al., 1979). These mutants were also cross 
resistant to other local anesthetics (dibucaine, lidocaine, and tetra­
caine) . Genetic analysis of these mutants may be difficult because cells 
were cultured continuously in the presence of procaine and were not cloned 
after selective treatment. In this investigation, however, cells resistant 
to the local anesthetic dibucaine were selected after mutagen treatment in 
a single step, thus cillowing the frequency of occurrence to be determined. 
These resistant cells are presumed to be single mutants. The plasma mem­
branes of local anesthetic resistant mutants and variants in mammalian 
cells have not been characterized; however, mutants of Escherichia coli 
resistant to the local anesthetic tetracaine exhibit a slight increase in 
the membrane protein:lipid ratio (Dame and Shapiro, 1978). 
Membrane Structure 
The plasma membrane rather than the cytoplasm is considered to be 
the primary target of local anesthetic action. The data which support 
this assumption includes the observation that axon-nerve impulses are 
blocked whether or not the cytoplasm has been removed from the cell (Baker 
et al., 1962; Frazier et al., 1970). Also, local anesthetics alter the 
fluidity and permeability to ions of artificial-bimolecular lipid 
membranes (Mueller.and Rudin, 1967; Papahadjopoulos et al., 1975). 
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Therefore, because anesthetics are assumed to bind with specific 
structures in the plasma membrane, a thorough knowledge of membrane 
structure is needed to understand the mechanisms involved in anesthetic-
induced effects on membrane-dependent functions. 
The Fluid Mosaic Model of membrane structure 
The Fluid Mosaic Model of membrane structure proposed by Singer and 
Nicolson (1972) is consistent with current membrane component chemistry. 
Briefly, this dynamic model proposes that a fluid lipid bilayer forms a 
matrix that is interlaced with globular protein. 
The cell's plasma membrane is composed of about 40% lipids. All 
membrane lipids are amphipathic and include the phospholipids, which are 
the major lipid component of the membrane; neutral lipids, mainly 
cholesterol; and glycolipids, largely glycosphingolipids (Bretscher and 
Raff, 1975). The long hydrocarbon chains (hydrophobic portion) of the 
fatty acids of these lipids are aligned toward the interior of the 
bilayer so that the polar heads (hydrophilic portion) are in contact 
with the aqueous environment. This provides the architectural framework 
of the lipid bilayer. 
At a specific temperature, the fluidity of the lipid bilayer depends 
on its phospholipid composition (Chapman et al., 1974). The phase 
transition of a phospholipid (the change from a liquid state to a rigid-
crystalline state) is determined by both the lipid head group, and the 
length and degree of saturation of the fatty acid side chains (Chapman 
et al., 1974). Moreover, the presence of cholesterol and protein modulates 
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the fluidity of the lipid bilayer in mammalian membranes (Bleau et al., 
1975; Kleeman and McConnell, 1976). 
The remaining 60% of the membrane mass consists of two classes of 
proteins. Peripheral proteins (extrinsic) are associated with the 
membrane surface by rather weak noncovalent forces. Integral proteins 
(intrinsic) are embedded more deeply in the lipid milieu. These proteins 
are asymmetrically oriented and some may traverse the entire lipid 
bilayer. 
There is substantial evidence for the lateral diffusion and inter­
mixing of various proteins in the plane of the membrane (Fahey and Koppel, 
1977; Bretscher and Raff, 1975). Frye and Edidin (1970) were the first 
to demonstrate the lateral migration of protein molecules in the lipid 
matrix. Mouse and human antigens were differentially labeled by tagging 
antibodies with fluorescent dyes. These antigens segregated into different 
regions of the membrane within 30 minutes after Sendai virus-induced fusion 
among mouse and human cells. Movement of protein receptors was not con­
sidered to be energy dependent because intermixing occurred in the absence 
of adenosine triphosphate (ATP) synthesis. Apparently, the fluidity of the 
membrane modulates protein migration because low temperature (4°C) retarded 
intermixing of membrane proteins. Two other forms of membrane protein 
redistribution (patching, the aggregation of membrane glycoproteins, and 
capping, the migration of these aggregated proteins to one pole of the 
cell) also are inhibited by low temperatures (Bretscher and Raff, 1975). 
Membrane fluidity is not the only factor that mediates the lateral 
mobility of integral proteins. Cytoskeletal structures, such as 
microfilaments and microtubules, are known to regulate receptor movement 
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(Nicolson, 1976a; Edelman, 1976). It was shown that capping, but not 
patching, was slightly impeded in the presence of cytochalasins, which 
are known to affect microfilament organization. The synergistic 
action of both cytochalasin and colchicine (a drug that disrupts micro­
tubules) severely inhibited capping (Bretscher and Raff, 1975). 
Bretscher and Raff suggested that this synergistic action was caused 
by microfilaments and microtubules establishing an "anchorage" for mem­
brane proteins, the assemblage and disassemblage of which would affect 
protein redistribution (Edelman, 1976). 
Local Anesthetic Action on Cell Membranes 
Studies of the mechanisms of local anesthetic action on cell membranes 
have evolved over a century. Initially, investigations were concerned with 
elucidating the mechanisms by which these drugs exerted their effects on 
nerve membrane conductance. Later, researchers turned to cultured cells 
with nonexcitable membranes to explore more fully the action of local 
anesthetics on the plasma membrane. It was discovered from these studies 
that local anesthetics dramatically affected other membrane-dependent 
functions (e.g., fusion, capping, exocytosis, phagocytosis, adhesion). 
Because the many attempts to define the molecular action of local 
anesthetics on excitable cell activity form the basis for the theories 
of anesthetic-membrane interaction, a discussion of these theories and 
supporting data is useful in developing an understanding of the 
mechanisms of local anesthetic-induced alterations in nonexcitable cell 
membranes. 
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Effects of local anesthetics on 
cells with excitable membranes 
During the resting potential, sodium (Na"^) ions are largely 
excluded from the inside of the cell with a compensatory increase in 
intracellular potassium (K^) ions. An initial influx of Na"*" ions 
depolarizes the membrane, thereby increasing the sodium permeability, 
which leads to further depolarization, i.e., the action potential. 
Depolarization is followed by an immediate increase in the permeability 
of the nerve membrane to K"*" ions that restores the resting potential by 
achieving a balance of electrical charges across the membrane. When 
applied to nerve cells, local anesthetics, e.g., procaine (4.6 mm), cocaine 
(2.6 mm), tetracaine (0.01 mm), dibucaine (0.003 mm), reversibly block 
nerve conduction by suppressing the initial influx of sodium (Na*) ions 
associated with the rising phase of the action potential without signifi­
cantly altering the resting membrane potential (Skou, 1954 ). 
Ionic channels in nerve membranes The selective blocking action 
of certain toxins or chemical agents on membrane depolarizations in nerve 
cells provided evidence of the existence of separate and distinct channels 
for ion flow (for review see Hille, 1970). The binding of tetrodotoxin 
to nerve membranes specifically inhibits Na"^ ion transport but does not 
diminish membrane permeability to K"*" ions. Conversely, the chemical 
tetraethylammonium specifically blocks K"*" conductance but never interferes 
with Na"*" flux. It is important to note that the presence of local anes­
thetics does not alter the binding of tetrodotoxin, which is believed to 
bind to the outside of the Na"*" channel (Hille, 1970) . This suggests 
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that local anesthetics do not act on the sodium channel at the 
tetrodotoxin binding site(s). 
Measurements from binding experiments with tetrodotoxin and tetra-
ethylammonium indicate that there are few Na"^ and K"*" ion channels 
(Ritchie, 1975; Hille, 1970). Although the relatively small number of 
channels makes direct experimentation difficult, it has been proposed that 
these channels are formed by a transmembrane protein containing a narrow 
slit (Hille, 1977). 
Physical-chemical characteristics of 
local anesthetics 
Anesthetics, which are drugs that abolish or at least diminish the 
sensation of pain, usually are categorized according to their method of 
administration into two classes, general and local. General anesthetics 
exert their effect on the central nervous system by being disseminated 
throughout the organism. On the other hand, local anesthetics are applied 
at specific sites proximal to nerve endings. Local anesthetics are 
classified further into two groups, hydroxyl compounds and amines. The 
hydroxyl compounds are alicyclic, aliphatic, or aromatic alcohols. Local 
anesthetics of the amine type have similar structural characteristics; 
they consist of an aromatic ring, an intermediate chain, and a primary, 
secondary, or tertiary amine. The amine types are commonly identified 
by the suffix "caine." Most likely, the nonpolar aromatic residue of 
amine local anesthetics is located in the hydrophobic interior of the 
plasma membrane, and the ionizable-amine end of these molecules is 
located at the membrane-water interface (Elferink, 1977; Strickholm, 1979; 
Singer, 1977). 
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At physiological pH, secondary and tertiary amine local anesthetics, 
e.g., procaine, lidocaine, cocaine, tetracaine, and dibucaine, exist as 
two molecular forms; protonated (positively charged) molecules, which 
are the predominant species, and neutral (uncharged) molecules. In 
contrast, the primary amine benzocaine and alkyl alcohols are not charged 
at physiological pH. If all local anesthetics act at a common target 
site, the uncharged species would be expected to be responsible for drug 
activity, because of those local anesthetics (benzocaine and alkyl 
alcohols) that are incapable of acquiring a proton at physiological pH. 
A considerable amount of experimental work has been done on the 
question of whether these drugs are effective in blocking nerve conduction 
in the uncharged or charged form. Skou (1954) and other investigators 
(Trevan and Block, 1927; Rud, 1961; Ehrenberg, 1948) reported that the 
uncharged-anesthetic molecule was more effective in blocking nerve activity. 
Similarly, Ueda and coworkers (1977), using pH titration curves, demon­
strated that the uncharged species was more active than the charged 
species in blocking ion conductance in artificial phospholipid vesicles. 
In contrast, Ritchie and Greengard (1961) and Narahashi and associates 
(1970) showed the protonated-local anesthetic was the more active form in 
blocking nerve conduction. For example, Narahashi and associates regu­
lated the intracellular pH of squid giant axons by internal perfusion. 
They found that when the intracellular pH was increased, with the extra­
cellular pH held constant, the blocking effectiveness of externally 
applied lidocaine decreased. Presumably, this increase in intracellular 
pH resulted in lidocaine predominantly existing in the uncharged form. 
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Some investigators have interpreted the dissimilarity of these data 
to mean that there are separate target sites for charged and uncharged 
anesthetic molecules (Ritchie, 1975; Strichartz, 1975). Ueda and coworkers 
(1976) suggested that the binding of the uncharged form implies that 
anesthetics nonspecifically interact with a hydrophobic region of membrane 
protein and/or lipid; whereas, the binding of a charged form may indicate 
an electrostatic or a hydrogen bond interaction representing site-specific 
binding. Therefore, both uncharged and charged anesthetics may contribute 
to the nerve block, but the extent of the contribution of each mechanism 
in inhibiting ion conduction is an open question. 
If local anesthetics act at a specific receptor site(s), the precise 
molecular shape of these drugs would be important in their activity. 
The aromatic amines show varying degress of stereospecificity. For 
example, the compound RAC 109 and cocaine are local anesthetics with two 
optical isomers, one of which is more potent on sciatic nerve (Akerman 
et al., 1969; Gottlieb, 1923). In contrast, (+) or (-) eucaines are 
equally active on sciatic nerve (King, 1924). 
Many researchers believe that the lipophilic character of anes-
thestics underlie their interactions with the hydrophobic core of the 
phospholipid membrane (for review see Kaufman, 1977; Seeman, 1972; 
Richards, 1978). Meyer (1899) and Overton (1901) independently 
observed that the potency of anesthetics is related to their solubility 
in olive oil. Meyer (1937) continued this approach by proposing that 
anesthesia was obtained when a certain concentration of drug dissolved 
in a certain volume of membrane lipid. Later work has supported this 
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by revealing a strong relationship between the nerve blocking potency 
of local anesthetics and their comparative membrane or lipid solubilities 
( Acceves andMachne, 1963). 
Monolayers, artificial bilayer membranes, bulk phase solvents, and 
oils are expanded in size by anesthetic penetration (Seeman, 1975). 
The swelling of most of these systems was approximately equal to the volume 
occupied by the anesthetic molecules themselves. Roth and Seeman (1972) 
provided data that local anesthetics resulted in expansion of biological 
membranes by measuring the surface area of erythrocyte ghosts. Because 
membrane expansion was determined to be much greater than the drug volume 
occupying the lipid bilayer, they concluded that expansion was not due 
solely to the presence of the anesthetic molecule. 
Supporting evidence that the intrusion of the anesthetic molecule 
itself is not causing the increase in volume was,provided by pressure-
reversal experiments. For example, Johnson and Flagler (1950) reported 
that hydrostatic pressures (150 to 350 atmospheres) restored the spon­
taneous swimming movements of anesthesized tadpoles. Later, Johnson and 
Miller (1970) found that increased cation permeability of artificial 
phospholipid vesicles produced by anesthetics was reversed by high 
pressure. Presumably, membrane expansion is related to anesthesia and the 
application of pressure compresses the swollen membrane back to its normal 
size, thus counteracting anesthesia. 
In addition, Seeman (1972) found that sublytic concentrations of 
anesthetics, which cause membrane expansion, resulted in membrane stabili­
zation. In other words, the cells were protected against osmotic, 
mechanical, or acid lysis in the presence of local anesthetics. These 
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results are consistent with other studies showing that .a lower osmotic 
fragility is associated with a higher area per volume cell ratio (see 
references in Seeman et al., 1969). 
The noted excess in membrane expansion has been suggested to be the 
result of conformation changes in membrane lipid. Studies using electron 
spin resonance (ESR) and nuclear magnetic resonance (NMR) spectroscopy 
have established that significant molecular disordering and fluidization 
of phospholipid in both natural and artificial membranes accompanies 
membrane expansion (Hubbell et al., 1979; Trudell, 1977). Some investi­
gators, however, argued that the overall fluidizing effects on membrane 
lipid were observed only at anesthetic concentrations well above those 
required to block nerve conduction or induced anesthesia (Richards, 1978-; 
Boggs et al., 1976). 
Papahadjopoulos and coworkers (1975) claimed to observe fluidity 
changes promoted by the local anesthetic dibucaine. They provided data 
that support the notion that anesthetic-lipid interaction may not be 
uniform in the plane of the plasma membrane, but is probably localized 
in specific lipid regions. Model membranes were used to show that there 
is a marked difference in the affinity of the cationic local anesthetic 
dibucaine (0.1 mM) for different types of phospholipids. The parti­
tioning of dibucaine was much greater in lipid vesicles (liposomes) 
composed of the acidic phospholipid phosphatidylserine than of liposomes 
constructed from the neutral lipid phosphatidylcholine. Furthermore, 
calorimetric and fluorescence polarization measurements, which determined 
the fluidizing effects of dibucaine on the lipid vesicle preparations 
showed that fluidity effects were confined to the vesicles constructed 
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from acidic phospholipid. No significant fluidity changes were detected 
in the neutral liposomes. Sv^jposedly, this asymmetric orientation could 
result in drastic fluidity changes in specific lipid domains that would 
be difficult to measure e^qperimentally in biological membranes. 
Theories of local anesthetic 
action on excitable cells 
It is not known which membrane components (e.g., lipid, protein, 
lipoprotein) local anesthetics interact with to cause their pharmaco­
logical effects. The possibility, however, exists that more than one 
component is involved (Richter et al., 1977). The phospholipid bilayer 
often is emphasized in the description of anesthetic-membrane interaction. 
Some investigators believe that anesthetic molecules act directly on mem­
brane proteins to bring about their effects. Others give preference to 
the involvement of membrane-bound calcium and some researchers stress the 
role of the membrane-associated cytoskeleton. 
Lipid change theories Trudell 11977) proposed a model to show 
how alterations in lipid fluidity may indirectly invoke conformational 
changes in membrane proteins that are responsible for the nerve impulse. 
He suggested that anesthetics fluidize the nerve membrane to such a degree 
that important lipid regions no longer contain phase separations, a condi­
tion where ordered gel (crystalline) phase phospholipid coexists with dis­
ordered fluid (liquid-crystalline) phase phospholipid (Shimshick and 
McConnell, 1973). The balance of the two lipid phases imparts a greater 
membrane compressibility that may facilitate conformational changes in 
integral proteins that reside in these areas. Thus, when anesthetics 
interact with membrane phospholipids, lateral phase separations are 
32 
disrupted, the nerve membrane becomes less compressible, and consequently 
the environment of the protein becomes more rigid. Hence, conformational 
changes in proteins become severely depressed. Trudell speculated on 
structural modifications that may be the basis of neutral function: 
(i) the pore of the sodium channel may undergo conformational changes to 
allow it to open for ion flow, (ii) ion flow may require the formation of 
the sodim channel by the ^  novo assembly of pore subunit s in the 
phospholipid bilayer. 
Alternatively, Lee (1976) suggested that the sodiun channel protein 
is surrounded by an annulus of lipid (boundary lipid) in the gel phase and 
that an open or active sodium channel is maintained by the rigidity of this 
lipid halo. Lee's model predicts that the penetration of anesthetics 
generates a change in the annulus of lipid to a more fluid phase, relaxing 
the channel to a more stable state. This relaxation causes the channel 
pore to narrow and consequently to inhibit ion conductance. 
This notion is plausible because the importance of phospholipid-
protein interaction has been suggested from work with several membrane-
2+ 
bound proteins, e.g., Ca ATPase of sacroplasmic reticulum membranes 
(Robinson et al., 1972; Warren et al., 1975), cytochromes of mitochondria 
monbranes (Jost et al. , 1973), and rhodopsin of the membrane from- retinal 
cones (Hong and Hubbell, 1972). Apparently, these proteins are tightly 
associated with a layer of lipid to stabilize them in their active state 
because they lose activity when associated phospholipid is removed. 
Klausner and coworkers (1979), like Lee, also proposed that drugs, 
which are membrane soluble, could disrupt membrane structure and function 
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by modifying protein-lipid interactions. Rather than drugs disordering 
membrane-annular lipid, which in turn alters the associated protein, 
these investigators suggested that drugs could bind to protein directly, 
causing a decrease in the rigidity of the surrounding lipid. Little 
attention has been given to the question of how critical protein struc­
ture is to the conformation and function of membrane lipid. 
This model was applied to the effects of the drug ionophore A23184 
on membranes. Like anesthetics, this lipophilic drug also interacts with 
both protein and lipid (Sarkadi et al., 1976); thus, the possibility 
exists that this ionophore is acting at the lipid-protein interface. When 
Klausner and coworkers (1979) compared the effects of ionophore on 
protein-reconstituted phospholipid vesicles and pure phospholipid vesicles, 
changes were observed only in the liposomes constructed with membrane 
protein; pure liposomes were not affected. The authors suggested that the 
ionophore molecule exerted a disordering effect only when lipids are in a 
specific configuration. The nature of the lipid configuration is obscure. 
This mechanism has not been applied to local anesthetics. 
Although it is not known if local anesthetics act on proteins or 
lipids to disrupt lipid-protein boundaries, evidence that local anesthetics 
interfere with the interaction at lipid-protein boundaries comes from 
studies by Elferink (1977). Fluorescent measurements were used to 
examine the binding of tetracaine and erythrocyte membranes. Addition 
of erythrocyte ghosts to a tetracaine solution (0.02 mm) results in a 
strong increase in fluorescence, thus indicating binding of the drug to 
the erythrocyte ghosts. Isolated ghost proteins plus liposomes of ghost 
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lipids added to tetracaine caused an increase in fluorescence but to a 
lesser degree than intact ghosts. Elferink interpreted this change in 
binding as resulting from the disruption of an interaction between 
protein and lipid phases in the intact membranes. 
Both Lee and Trudell's hypotheses assume that a transmembrane 
protein forms the sodim ion channel. Furthermore, both theories are 
not specific; theoretically, the transport of any substance mediated by 
a similar transmembrane-protein channel could be affected by local 
anesthetics. 
The first demonstration that local anesthetics can alter the function 
of a protein constituting a membrane-ion channel was provided in a study 
using nonexcitable cells (Feinstein et al., 1977). In erythrocytes, evi­
dence has been provided that ions travel through transmembrane protein 
channels (Naccache and Shaa'fi, 1974). Strong evidence shows that a spe­
cific protein, referred to as Band 3 protein (isolated from red blood cell) 
membranes), is an anion channel that controls the movement of sulfate 
—2 (SO^ ) ions across the membrane (Rothstein et al., 1976; Ho and 
Guidotti, 1975). Feinstein and coworkers (1977) showed that sulfate 
permeability in erythrocytes is severely inhibited in the presence of 
dibucaine (0.05 to 1.0 mM) or tetracaine (0.5 to 3.0 mM). Concentrations 
of procaine vç to 10 mM had no effect on SO^ ^  transport. This may 
suggest that procaine binds to Band 3 protein at a site different from 
that involved in sulfate transport. In addition, Feinstein and coworkers 
found that dibucaine and tetracaine notably blocked Band 3 protein 
facilitated transport in reconstituted liposomes, an effect not reproduced 
in pure liposomes. Because only a slight fluidity difference was observed 
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in erythrocyte membranes at the drug concentrations used, these investi­
gators believe that the anesthetic effects on this transport protein is 
probably not induced by means of altering the generalized membrane 
fluidity. Nevertheless, it remains to be established whether local 
anesthetics affect either the protein directly or the lipid milieu en­
compassing the protein. 
Protein conformation model Some investigators (Eyring et al., 
1973; Seeman, 1975; Metcalfe et al., 1968, 1974; Halsey, 1974; Richards 
et al., 1978) have focused attention on proteins as the site of drug 
interaction because local anesthetics show various degrees of stereo-
specificity (Akerman et al., 1969; Gottlieb, 1923), and charged local 
anesthetics act from only the inside of the plasma membrane (Narahashi 
et al., 1970). They feel that anesthetic-induced membrane expansion is 
the result of extensive conformation changes in membrane proteins. 
Anesthetic interaction with functional membrane proteins is viewed in 
several ways: (i) the drug molecule simply plugs the sodium channel; 
(ii) the drug molecule alters the channel protein's structure and renders 
it inactive; (iii) the drug molecule renders the channel protein 
incapable of a conformation change necessary for neural function. 
Although there is no information on structural changes induced 
by local anesthetics on proteins of nerve membranes, data exist for 
drug-protein interactions on pure proteins isolated from nonexcitable 
cell types. For example, relaxation measurements on the effects of 
benzyl alcohol on extracted erythrocyte protein led Metcalfe and coworkers 
(1968) to initially suggest that anesthetics could interact with the 
protein fraction of the membrane. Furthermore, measurements of optical 
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rotation on pure protein so lut ions, such as bov:ine plasma albumin, crystal­
lized lactoglobulin, hemoglobin, and myoglobin indicated reversible changes 
in alpha and beta content in the presence of anesthetic agents 
(Balasubramanian and Wetaufer, 1966). 
Udea and coworkers (1976) conducted studies with luciferase, an en­
zyme associated with bioluminescence, to show protein alteration in the 
presence of anesthetics. Addition of general or local anesthetics to cell-
free firefly tail extracts repressed the light emitting reaction and caused 
luciferase to have a larger volume. This effect could be reversed by 
hydrostatic pressure. Thermodynamic analysis suggested that the enzyme 
was being unfolded by the anesthetics and that the application of pressure 
presumably reversed this conformational change. Furthermore, studies on 
the effects of temperature and pH upon the inhibitory action of local anes­
thetics showed that the drugs were predominantly interacting in hydrophobic 
portions of luciferase and to a lesser degree, hydrophilic regions. 
They interpreted these findings to mean that the decrease in light 
intensity is due to a derangement of luciferase caused by a direct-drug 
interaction. The structural change in the protein is believed to cause 
neutralization of charged groups, which in turn results in the release 
of water molecules bound to hydrophilic sites on the enzyme. The change 
in conformation may be envisioned as some type of unfolding of the pro­
tein, so that it occupies a larger volume in the phospholipid bilayer. 
A protein conformational change can be viewed nonspecifically, like 
a lipid conformational change, because it involves drug interaction with 
the hydrophobic regions of a protein likely to be common to most intrinsic 
membrane proteins embedded in the interior of the lipid matrix. 
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Local anesthetic action and the role of membrane-bound calcium 
Blaustein and Goldman (1966a) suggested a model to describe how the 
mechanism of anesthetic action involves membrane-associated calcium. They 
speculated that phospholipid molecules of the nerve membrane form spaces 
that provide a passageway for potassium and sodium ion flow. A 
cationic anesthetic is assumed to insert its lipophilic-aromatic ring 
among the fatty acid chains of phospholipids, with its charged amine 
group close to the polar head of the phospholipids. The inserted drug 
leads to the neutralization of the negative charge on the phospholipid 
polar head. Consequently, fewer phospholipid-binding sites are available 
for divalent calcium. Therefore, calcium is displaced from the membrane 
and no longer available for the generation of the nerve impulse. 
Papahadjopoulos (1970) provided evidence that local anesthetics 
could neutralize the negative charge on phospholipids. Observing 
electrophoretic mobility, he demonstrated that the negative charge on 
lipid vesicles composed of phosphatidylserine was diminished in the 
presence of local anesthetics. 
Moreover, an accumulation of data has shown that local anesthetics 
readily compete., and displace membrane-bound calcium from its fixed 
negative sites (Papahadjopoulos, 1970; Blaustein and Goldman, 1966a; 
Peinstein, 1964;Acceves and Machne, 1963). Feinstein (1964), for example, 
reported the competitive binding of cationic local anesthetics with 
calcium to phospholipids. Through the use of a two-phase model system 
(chloroform;water), he found that these drugs inhibited the phospho-
lipid-mediated transport of calcium into the chloroform phase. 
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Blaustein and Goldman (1966a), using similar methods, confirmed Feinstein' 
observations with a variety of local anesthetics, and demonstrated that 
this inhibition of calcium binding was correlated to the anesthetic 
potency of the drug. 
Many investigators have documented that the addition of extra­
cellular calcium antagonizes the inhibitory actions of local anesthetics 
on artificial and natural membranes (Poste and Reeve, 1972; Stygall et al. 
1979; Fogler et al., 1978; Papahadjopoulcs/ 1970) . As an example, the inter­
action of calcium and procaine (4.0 Mm) on lobster axon was assayed by a 
voltage clamp technique (Blaustein and Goldman, 1966b), which permitted 
the precise measurement of membrane-conduction changes that accompany 
the action potential. An increase in calcium concentration paralleled 
a decrease in the effectiveness of procaine in blocking sodium con­
ductance. Conversely, procaine was more effective in blocking the 
membrane's action potential if the amount of external calcium was reduced. 
Such antagonism implies that calcium and local anesthetics compete with 
each other at the same sites. 
Not all local anesthestics displace membrane calcium. The anionic 
drugs, e.g., pentobarbital, increase the binding of calcium to the 
membrane. Blaustein and Goldman (1966a) suggested that the nega­
tive head of the anionic anesthetic molecule tends to increase 
the binding of calcium by neutralizing the cationic nitrogen on the 
phospholipid molecule. This tightly bound calcium affects neuron 
function because it is not available for the calcium influx needed for 
the action potential. 
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The model by Blaustein and Goldman depends on local anesthetics 
possessing a charge. Their model does not account for the anesthetic 
effectiveness of neutral agents, such as benzocaine. Moreover, their 
model assumes that the competing site is a phospholipid molecule. However, 
there are no studies describing the interaction of local anesthetics with 
protein-bound calcium. The major fraction of membrane calcium is 
associated with protein (Porstner and Manery, 1971). It remains to be 
determined if the majority of calcium is being removed from lipid or 
protein. 
Microtubular model Local and general anesthetics have been 
reported to cause the breakdown of microtubules in both nerve axons and 
other cell types (Allison and Nunn, 1968; Nicolson et al., 1976; Ojakian 
et al., 1977). Allison and Nunn (1968) suggested that the disruption of 
microtubules may be the basis for anesthesia. Microtubules are present 
in nerve axons, but the exact function they play in ion conduction is 
uncertain (Kaufman, 1977). Because high concentrations of drugs, e.g., 
0.2aiM dibucaine,over that needed to inhibit the nerve impulse, e.g., 
0.005 mM dibucaine, are used to obtain microtubular depolymerization, it 
is doubtful that this serves as a basis for the inhibition of nerve con­
duction (Kaufman, 1977). Furthermore, one group showed that colchicine, 
a microtubular inhibitor, had no effect on electrical activity (Hinkley 
and Green, 1971). 
Simply, microtubular breakdown in nerve cells may be incidental to 
anesthesia (Kaufman, 1977). Yet strong evidence gathered from non-
excitable cell types indicates that indeed, microtubular and 
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microfilament disruption caused by local anesthetics may be a primary 
mechanism for the interference of membrane functions (e.g., fusion, 
capping, adhesion, and spreading) other than the nerve impulse of excit­
able cells. This point is considered in detail later in this review. 
Cell surface difference and local 
anesthetic activity 
It should be pointed out that theories of anesthetic action on nerve 
cells are sometimes supported by evidence derived from both artificial 
systems and cells of other tissue types. Admittedly, such extrapolative 
approaches may have their limitations. The behavior of model membranes is 
presumed to be similar to properties of natural membranes. Moreover, in 
natural membranes, what may be the accepted fact for the plasma membrane 
of one tissue type (e.g., nerve) may not be true for the membrane of 
another tissue (e.g., erythrocyte). It is well-known that the cell 
membranes from different tissues contain characteristic proteins (Quinn, 
1975). In addition, plasma membranes may vary in the proportion of 
protein to lipid or cholesterol to lipid. Moreover, the species of lipid 
molecules may differ in proportion (Quinn, 1975). Considerable dif­
ferences in membrane-fatty acid chain length and degree of unsaturation 
have been documented, and therefore, membranes may vary in viscosity 
(Chapman, 1975). 
The first demonstration of surface differences and local anesthetic 
activity was reported by Cheng and coworkers (1978). These investigators, 
using the ANS (l-anilinonaphthalene-8-sulfonate) fluorescent probe, demon­
strated that the ability of procaine to displace calcium from heptatoma 
cells (neoplastic) was reduced by 40% compared with normal hepatocytes. 
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It was suggested that the difference in the neoplastic cells may be due 
to either calcium binding more tightly to its membrane sites or calcium 
binding at sites inaccessible to procaine. This is conceivable because it 
is well-established that structural and binding alterations exist between 
neoplastic and normal membrane (Burger, 1975). 
Effects of local anesthetics on cells 
with nonexcitable membranes 
Local anesthetics are useful biological probes for the investigation 
of relationships between mammalian membrane architecture and function 
because of their dramatic effects on membrane-dependent phenomena in 
nonneural cells. 
Cell shape and motility Spreading and adhesion are cellular 
functions that require changes in membrane motility, which in turn cause 
changes in cell shape. Evidence indicates that cell spreading and ad­
hesion are intimately related to each other. Both of these membrane 
functions are temperature and divalent cation dependent (Rabinovitch and 
DeStefano, 1973), and may require cytoskeletal structures, i.e., micro­
filaments and microtubules (Weiss, 1972). 
Rabinovitch and DeStefano (1975) demonstrated local anesthetic-
induced inhibition of cell to substrate adhesion by inoculating radio-
actively-labeled (chromium; ^^Cr) sarcoma (Sal) cells on glass cover-
slips and measuring the amount of radioactivity remaining on the cover-
slips after drug exposure. In 20 minutes, the cells adhered to the 
cbverslips. When treated with tetracaine (0.5 mM) or cyclomethylcaine 
(0.1 mM), for 10 minutes followed by washing in drug-free medium, the 
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glass-associated radioactivity was significantly reduced because of cell 
detachment from the glass substrate. Additionally, several tranquilizers 
(promethazine, chloroproraazine, fluphenazine), which are another class of 
drugs with pharmacological activity, showed effects comparable to local 
anesthetics. 
Rabinovitch and DeStefano (1976) observed the effects of local 
anesthetics on cell spreading by time lapse photography. They demon­
strated that the presence of cationic anesthetics (lidocaine, 12 mM; 
procaine, 20 mM; tetracaine, 1.5 mM; dibucaine, 0.4 mM; and benzocaine, 
5 mM) affected cell shape. When cultivated macrophages were exposed to 
these agents, the cells recoiled, ceased to form large cytoplasmic pro­
jections (pseudopods), and stopped membrane ruffling activity. The spread 
cells contracted and then rounded after 10 to 15 minutes of exposure to 
an anesthetic. The concentrations of different anesthetics required for 
cell rounding was inversely proportional to their membrane solubilities. 
Different levels of Ca^"*", Na^, or magnesium (Mg^^) did not influence the 
effectiveness of anesthetic drugs on cell shape. Anesthetic-induced cell 
shape changes were not mediated by changes in sodium conductance because 
tetrodotoxin was ineffective in producing cell-shape alterations. Fur­
thermore, quaternary local anesthetics, which are slow permeants and only 
block nerve conduction when applied to the cytoplasmic side of the plasma 
membrane, also were ineffective in disrupting cell spreading when added 
to the culture medium. This is indicative of either an intracellular 
anesthetic-target site or a target site at the cytoplasmic side of the 
plasma membrane. 
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The effects of colchicine, a microtubular inhibitor, were 
evaluated to establish if polymerized tubulin is required for either 
anesthetic-induced cell rounding or the renewal of cell spreading upon 
drug removal (Rabinovitch and DeStefano, 1976). When macrophages were 
pretreated with colchicine (0.005 mM), followed by lidocaine treatment, 
extensive cell rounding resulted. Respreading still occurred when lido­
caine was removed from the culture and the cells were perfused with growth 
medium supplemented wich colchicine. Apparently, polymerized tubulin does 
not play a role in either anesthetic-induced rounding or revival of the 
spread conformation. Nevertheless, the cytoskeleton has been implicated 
in cell adhesion and the maintenance of cell spreading in response to 
interactions of the plasma membrane to the substrate by others 
investigators (Godman et al., 1975; Goldman et al-, 1973, 1975; Juliano 
and Gagalang, 1979). 
Based on the proposed theories of action on excitable cells 
(Seeman, 1972; Richards, 1978), Rabinovitch and DeStefano (1976) suggested 
that local anesthetics influence cell surface dynamics by one or 
more of the following mechanisms: (i) direct or indirect anesthetic 
interaction that results in a conformation change in a transmembrane 
protein responsible for signaling information on the nature of the 
substrate; (ii) anesthetics directly or indirectly disrupt some part of 
the cytoskeletal system, presumably the contractile microfilaments; 
(iii) anesthetic-induced displacement of membrane-hound calcium and 
a subsequent increase in intracellular calcium that may disrupt the 
function of microfilaments (Izzard and Izzard, 1975). 
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Because local anesthetics are known to interfere with energy 
metabolism by reducing ATP levels (Michenfelder and Theye, 1972; 
Brunner et al., 1975), the possibility exists that the interruption of 
cell spreading and adhesion simply may be a consequence of the inter­
ference of these agents with energy metabolism. Rabinovitch and 
DeStefano (1976), however, reported that two metabolic inhibitors, sodium 
azide (1 mM), and rutamycin (lug/ml), did not mimic the effects of local 
anesthetics on adhesion of sarcoma cells. 
Cell agglutination Poste and coworkers (1975a) provided addi­
tional evidence that local anesthetics alter membrane-surface topo­
graphy and mobility. They examined the effects of several cationic amine 
anesthetics on cell agglutination mediated by the plant lectin concanava-
lin A (ConA) . Cell agglutination requires a redistribution of membrane 
receptors. When mouse 3T3 cells were exposed to dibucaine (0.1 mM) , tetra­
caine (0.5 mM), or procaine (5 mM) for 30 minutes, a significant enhance­
ment of cell agglutination induced by low concentrations of ConA was 
observed. This effect was di;plicated by the synergistic action of both 
cytochalasin B (5pg/ml) and colchicine (0.001 mM). 
Because it is commonly believed that microtubules restrict cell 
surface receptor mobility by establishing an "anchorage" for membrane 
proteins, the action of local anesthetics on cell agglutination was 
interpreted as a disruption of the microtubular "anchorage" with subse­
quent facilitation of receptor distribution by multivalent ligands such 
as ConA (Poste et al., 1975 a, b) . Microtubular alterations were assumed 
to be mediated by anesthetic-induced calcium displacement because 
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Poste and coworkers (1975a) found that enhanced cell agglutination 
caused by the presence of dibucaine was reversed by the addition of 
calcium. 
Capping of cell surface receptors The membrane phenomena 
of patching and capping illustrate another situation that involves 
cytoskeletal-transmembrane control of surface receptors. Patching, 
which involves the formation of dense aggregates of surface receptor 
sites after multivalent-ligand binding, is not affected by local anes­
thetics, cytochalasin, or colchicine. However, capping the migration 
of these aggregated proteins to one pole of the cell, is appreciably 
inhibited by local anesthetic treatment (Schreiner and Unanue, 1976; 
Poste et al. , 1975b; Ryan et al., 1974). 
The inhibitory effects of local anesthetics on capping can be 
mimicked by the synergistic action of both cytochalasin and colchicine 
(Poste et al.., 1975b; Bretscher and Raff, 1975). This implies the 
involvement of microfilaments (MF) and microtubules (MT) in capping and 
suggests that the MT-MF system is affected by anesthetic treatment. 
Moreover, the effects of local anesthetics on capping can be counteracted 
by elevated levels of extracellular calcium, which may prevent the 
severing of microfilament-membrane linkages or microtubular breakdown. 
These data further suggest that anesthetics compete and remove calcium 
from its membrane sites. 
The disruption of microtubules and microfilaments Studies 
using electron microscopy provided firm evidence for the view that 
local anesthetics may disrupt transmembrane regulation and cell surface 
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dynamics by indirectly or directly acting on calcium-sensitive cyto­
skeletal proteins. As observed in macrophages and sarcoma cells (Rabino-
vitch and DeStefano, 1975, 1976), Ojakian and coworkers (1977) reported 
changes in cell shape of fibroblasts treated with the local anesthetic 
dibucaine. Before cell rounding, electron microscopy revealed an exten­
sive disaggregation of microfilament bundles into single filaments. 
Although seme intact microtubules were seen using anti-tubulin immuno­
fluorescence, most of the microtubular system was disrupted. Because 
these gross changes preceded cell rounding, the authors concluded that 
anesthetic-induced cell shape changes may be the direct or indirect 
result of microfilament-microtubular breakdown. Similarly, Nicolson 
and coworkers (1976) showed dramatic alterations within 15 to 30 minutes 
on both cell shape and membrane-associated cytoskeletal elements in 
BALB/3T3 mouse cells by dibucaine (0.2 mM), tetracaine (0.5 to 1 mM), and 
procaine (1 mM). 
Because microfilaments and microtubules are apparently affected 
by the intracellular concentrations of calcium ions. Poste and associates 
(1975b) suggested that cytoskeletal breakdown occurs by anesthetic-induced 
displacement of membrane-bound calcium and a subsequent increase in 
cytoplasmic calcium. The depolymerization of tubulin, which polymerizes 
to form microtubular structures, is favored by an elevated amount of 
calcium, approximately 10 (Nicolson et al., 1976). Presumably, 
calcium may be involved in the linkage of the microfilamentous network 
to the plasma membrane (Nicolson et al., 1976). 
Shier (1977) proposed an alternative mechanism by which microfilament-
microtubular integrity may be affected by local anesthetics. He found that 
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lysolecithin acyltransferase activity was severely retarded in baby kidney 
hamster (BHK) cells when in the presence of dibucaine (0.016 mM), lidocaine 
(1.6 mM), tetracaine (0.075 mM), or procaine (2 mM) for 45 minutes. 
Because lysolecithin acyltransferase catalyzes the resynthesis of 
lecithin (phosphatidylcholine), which is a major class of phospholipid 
in cell membranes, from lysolecithin, an inhibition of this activity 
would result in an increase in the level of lysolecithin in the plasma 
membrane. Shier hypothesized from these experiments that an accumulation 
of lysolecithin may disperse cytoskeletal structures directly or in­
directly because of its detergent properties. This can occur either 
by direct interaction of lysolecithin with microfilaments and/or 
microtubules, thus causing their disruption, or by lysolecithin increas­
ing the permeability of the plasma membrane to calcium ions and the 
increase in cytoplasmic calcium resulting in the disruption of micro­
filaments and microtubules. 
Plasma membrane fusion A membrane process that involves the 
uniting of the plasma membrane between two or more cells is referred 
to as cell fusion. The inhibition of cell fusion demonstrates 
another instance of local anesthetic interference of membrane phenomena. 
Like cell spreading, agglutination, and capping, membrane fusion 
involves the movement and rearrangement of the membrane. 
Poste and Reeve (1972) found that local anesthetics (procaine, 
tetracaine, lignocaine, dibucaine) and tranquilizers inhibited cell 
fusion induced by both virulent and nonvirulent (inactivated) viruses. 
This inhibition was not brought about by the impairment of viral 
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replication. Also, the anesthetic potency of these drugs in reducing 
cell fusion correlated with their membrane solubilities. The effective­
ness of these anesthetic agents in blocking virus-induced fusion was 
reduced significantly in the presence of extracellular calcium. This 
observed antagonism of calcium on anesthetic activity is significant 
because the displacement of calcium ions from the plasma membrane is 
considered to be an essential step in membrane fusion (Poste and Allison, 
1973). Poste and Reeve (1972) suggested that local anesthetics nonspeci-
fically inhibit virris-induced fusion by elevating the dissociation of 
membrane-bound calcium and then competing with calcium for its binding 
sites. Hence, the occupation of calcium binding sites by anesthetic 
molecules would make these ionic sites inaccessible for the inter-
digitation of closely apposing membranes. 
Myogenesis, which is an essential step in muscle differentiation, 
is a natural and regularly occurring event that involves membrane fusion 
among mononucleated precursor cells (myoblasts) to form elongated multi­
nucleated cells (myotubes). Stygall and coworkers (1979) reported that 
exposure to cocaine (1 to 2 mM), lignocaine (1 to 2 mM), mepivacaine 
(1 to 2 mM), or bupivacaine (0.5 mM) reversibly prevented the fusion 
of myoblasts to myotubes in newborn rat skeletal muscle in vitro. This 
was also true for an anionic barbiturate, another nerve blocking agent. 
The addition of extracellular calcium up to 20 mM was ineffective in 
retarding bupivacaine-induced inhibition of myotube formation. This is 
in contrast to the ability of calcium to suppress the inhibitory effects 
of local anesthetics on virus-induced fusion (Poste and Reeve, 1972) . 
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The maturation and budding of enveloped viruses from host-plasma 
membranes involves membrane fusion. For example, the maturation of 
Semliki Forest (SF) virus requires the synthesis of 3 viral glycoproteins 
that migrate to the host's membrane. It is believed that these viral 
envelope proteins merge with the plasma membrane and subsequently form 
patches that exclude proteins of the host cell. Independently, the viral 
nucleocapsid, composed of single-stranded RNA, also moves towards the 
host's membrane and interacts with the patches of viral glycoproteins. 
Then a fusion process occurs that results in the release of virus parti­
cles and leaves the host plasma membrane intact (Richardson and Vance, 
1978a). 
Richardson and Vance (1978a) found that 3 hours after SF viral 
infection, the addition of dibucaine (0.1 mM) interfered with this 
budding process, and dramatically reduced the production of SF virus 
by 90% from baby hamster kidney (BHK) cells. They used pulse chase 
studies to show that dibucaine inhibition occurred after the viral 
proteins had reached the host's membrane. Because colchicine (0.05 mM) 
also blocked viral budding, which occurred after viral-protein migration, 
the microtubular system may be involved in virus maturation. Unlike 
colchicine, dibucaine (0.1 mM) was not found to disrupt polymerized 
tubulin by measuring the amount of polymerized tubulin ijri vitro isolated 
from drug treated cells. These results are contrary to those of Ojakian 
et al., (1977) and Nicolson et al., (1976) who observed microtubular 
breakdown in dibucaine treated fibroblast and BALB/3T3 mouse cells by 
examination using electron microscopy. 
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Richardson and Vance (1978b) further examined the effects of 
both dibucaine and colchicine on the chemical cross-linking of viral 
proteins within the host's membrane by dimethyl 3,3^-thiobis (propionim-
idate) or dithio (succinimidyl propionate). Colchicine did not interfere 
with this reaction, but dibucaine inhibited cross-linking of the viral 
glycoproteins. These investigators showed that the cross-linking 
reaction was not prevented in purified SF virus by dibucaine- Therefore, 
dibucaine probably did not inhibit chemical cross-linking by simply 
separating the viral envelope proteins by its interpolation into the host 
plasma membrane, Richardson and Vaince (1978b) suggested that dibucaine 
is preventing the aggregation of the viral envelope proteins within the 
host's membrane. They further hypothesized that the host cell micro­
filaments may be responsible for the formation and maintenance of these 
viral-protein aggregates. Therefore, they suggested that microfilaments 
function as a site for anesthetic action. Because the microfilament 
inhibitor cytochalasin B prevented viral budding and dibucaine has been 
shown to disrupt microfilaments in other studies (Nicolson et al., 1976), 
conceivably, dibucaine could disaggregate microfilaments and thus impede 
formation of viral-protein patches in the BHK-cell membrane. They 
suggested that microtubules were required for the stabilization of the 
viral bud formed before the fusion event that results in extracellular 
virus. 
Exocytosis Exocytosis is the cellular release of secretory 
products, which aire encapsulated within membr^jie limited vesicles, by 
fusion of these vesicles with the plasma membrane of the cell. Local 
anesthetics have been shown to diminish this process in a variety of 
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secretory cells, e.g., beta cells of the pancreas (Bressler and Frendel, 
1971), platelets (Feinstein et al., 1976), mast cells (Kazimierczak et al. 
1976), chromaffin cells (Rubin et al., 1967), and the acrosome reaction 
of the sea urchin sperm (Collins and Epel, 1977). Secretory products 
that are encapsulated within membrane-limited vesicles are expelled when 
the vesicles fuse with the plasma membrane. 
In contrast, in nerve cells, the fusion of intracellular-bilayer 
vesicles (which contain neurotransmitting chemicals) with the presynaptic-
plasma membrane is not inhibited but significantly enhanced in the 
presence of anesthetics (Seeman, 1972; Quastel et al., 1971). Seeman 
(1972) suggested that this facilitated release of neurohumors into the 
synaptic gap may be the result of increased membrane lipid fluidization 
attributable to anesthetic penetration. On the other hand, an inhibition 
of exocytosis in other cell types may be due to the ability of these 
drugs to displace membrane-associated calcium from fixed sites that are 
involved in the fusion process (Poste and Allison, 1973). This view is 
supported by studies which showed that the inhibitory effects of local 
anesthetics on acrosomal secretion by sea urchin sperm (Collins and 
Epel, 1977) and on catecholamine secretion by chromaffin cells (Rubin 
et al., 1967) was counteracted by raising the extracellular calcium con­
centration. The effects of these agents on insulin secretion by the 
pancreas, however, were not reversed by extracellular calcium (Bressler 
and Frendel, 1971). 
Phagocytosis Phagocytosis is the uptake of particulate matter 
by cells and involves the envelopment by the particle being ingested. 
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Different regions of the plasma membrane contact and then fuse, thus 
resulting in the formation of a membrane-enclosed phagocytic particle. 
Fogler and coworkers (1978), using radioactively labeled (^^Cr) 
opsonized sheep red blood cells (the ingestible particles), showed that 
the local anesthetics, dibucaine (0.08 mM), procaine (10 mM), or tetra­
caine (0.2 mM) exerted a reversible inhibition on cellular engulfment by 
mouse peritoneal macrophages. After the addition of labeled ingestible 
particles, the cell-associated radioactivity was greatly diminished when 
macrophages were pretreated for 2 hours with these anesthetics. These 
inhibitory effects were the result of the anesthetic agents acting on 
the macrophage itself and not due to the interaction of the drugs on 
the phagocytic stimulus, i.e., opsonized sheep red blood cells. Similarly, 
the inhibition of phagocytosis by local anesthetics has been reported 
with other cultured cells using variety of phagocytotic particles, 
such as red oil droplets (Goldstein et al., 1977) and latex particles 
(Cullen and Haschke, 1974). 
Also, Fogler and coworkers (1978) found a positive relationship 
between the potencies of local anesthetics in inhibiting phagocytosis 
and their membrane solubilities. In other words, much more procaine 
(10 mM), which has a low membrane solubility, was required to cause a 
50% inhibition of phagocytosis then dibucaine (0.08 mM), which is very 
lipid soluble. In addition, the inhibitory effects of phagocytosis of 
local anesthetics were blocked by addition of calcium. This antagonism 
of calcium prompted Fogler and coworkers to suggest that anesthetic-
induced displacement of membrane associated calcium resulted in the 
breakdown of the microfilaments and microtubules. These cytoskeletal 
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elements have been implicated in the regulation of phagocytosis (Reaven 
and Axline, 1975). 
Gersten and Fogler (1979) extended these studies and demonstrated 
that the local anesthetic tetracaine interfered both with particle 
recognition by the receptors on the cell surface and at the level of 
the actual engulfment of particulate matter. They suggested that the 
basis of anesthetic-induced inhibition of recognition is steric. Tetra­
caine probably disrupts the transmembrane control of the Fc receptor, 
which recognizes the oponizing antibody attached to the sheep red blood 
cells (SRBC). Consequently, clustering of the surface receptors occurs, 
and binding of oponized SRBC is sterically impaired. The mechanism by 
which ingestion is blocked is less clear but may also involve the cyto-
skeleton. 
Summary 
The ion permeability of both nerve membranes and artificial membranes 
has been shown to be affected by local anesthetics. In addition, studies 
using cultured somatic cells with nonexcitable membranes have demonstrated 
that these drugs interfere with membrane behavior that seem to involve 
the mobility and rearrangement of the plasma membrane. The molecular 
events associated with these anesthetic-induced alterations in plasma 
membrane function are obscure. It is widely accepted among investigators 
that no unitary mechanism of anesthetic action exists (for references see 
Kaufman, 1977). Although local anesthetic induced-membrane fluidization, 
displacement of membrane bound calcium, protein conformational changes. 
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and disruption of cytoskeletal structures may occur simultaneously, only 
one of these mechanisms may predominate in the alteration of a particular 
cell function. 
The possibility exists that local anesthetics interact with the 
plasma membrane in a nonspecific and specific fashion to bring about their 
effects. Some evidence implies that specific membrane receptor(s) for 
local anesthetics may exist (e.g., sterospecificity and anesthetic inter­
action at the cytoplasmic side of the plasma membrane). Nevertheless, it 
has not been demonstrated that these drugs are associated with a membrane 
component that can be correlated with biological activity. Other data 
indicate that local anesthetic-membrane interaction is a nonspecific 
hydrophobic reaction, because of the diversity of lipophilic drugs (e.g., 
general anesthetics, barbiturates, tranquilizers) that affect cells 
similarly as local anesthetics. However, a nonspecific biophysical reaction 
with the plasma membrane does not imply a unitary mechanism at the cellular 
level. The precise molecular mechanism of sequential events following the 
hydrophobic-anesthetic interaction with the cell membrane may be different 
and very specific for an anesthetic-induced alteration of a particular 
cell function (e.g., ion transport, fusion, capping, phagocytosis, exo-
cytosis). 
The isolation of somatic cell mutants resistant to a local anesthetic 
may provide information about the membrane components involved in 
anesthetic action and how anesthetic interaction with these structures 
brings about the alteration of membrane dependent functions. This in turn 
may advance our understanding of the relationships between membrane 
structure and function. 
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MATERIALS AND METHODS 
Cell Lines 
The mouse cell lines GF7 and GF9 were used in this study. These 
sublines were derived as mutant clones from the lymphocytic parent line 
L5178Y after treatment with the mutagen ICR-372 (Figure 1). L5178Y was 
first isolated by Law from a leukemic mouse and later cultured ^  vitro 
by Fischer (1958). GF7, used as the parent cell line in all mutagenesis 
experiments, lacks thymidine kinase (TK~) and GF9, used as a parental 
line in the cell hybridization experiments, is deficient in hypoxanthine; 
guanine phosphoribosyl transferase (HPRT~) . Both GF7 and GF9 are pseudo-
diploid and neoplastic. 
Cells were maintained routinely in suspension culture in Fischer's 
medium (Table 1) buffered with sodium bicarbonate (Na2HC03) and supple­
mented with 10% (volume/volume) heat-inactivated horse serum, penicillin 
(100 units/milliliter) and stretomycin (10 micrograms/milliliter). Cells 
were incubated at 37°C in an atmosphere of 95% air and 5% carbon dioxide 
(CO2). The pH of the growth medium was adjusted with either 0.5N or l.ON 
hydrochloric acid (HCl) to a range of 7.5 to 7.8. The normal population 
doubling time (Td) was 11 to 13 hours. 
Because the incubator adjusted at 33°C was not equipped with a flow 
of CO^ gas, a subpopulation of GF7 cells, used for the isolation of tem­
perature-sensitive mutants, was adapted for growth at 33°C in the air 
atmosphere. The growth medium used for this purpose was Fischer's medium 
(without Na^HCO^) buffered with 10 millimolar (mM) Hepes and svpplemented 
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Figure 1. Derivation of mouse lymphoid cell lines GF7 and GF9 (genotypes are defined under each cell 
line: ASN" '= asparagine requiring mutant; HPRT = hypoxanthine:guanine phosphoribosyl 
transferase; TK = thymidine kinase; (+) = wild type enzyme; and (-) = defective enzyme) 
57 
























































Ascorbic acid 52.000 




Pyridoxal HCl 0.550 
Niacin 0.125 
Nicotinamide 2.500 
Ca pantothenate 2.500 
Pyridoxine HCl 2.000 
Riboflavin 0.550 
Thiamine HCl 5.000 
Folic acid 2.000 
Biotin 0.150 
Phenol red 5.000 
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maintained in the same kind of growth medium. Cell population doubling 
time was 20 to 24 hours at 33°C and ranged from 12 to 14 hours at 39°C. 
Media and Chemicals 
Fischer's medium and trypan blue were purchased from Grand Island 
Biological Supply Company (GIBCO), Grand Island, New York. Horse serum 
was obtained from either Microbiological Associates or GIBCO. Nobel agar 
was purchased from Difco. Ethyl methane sulfonate, penicillin, strepto­
mycin, benzocaine, procaine HCl, tetracaine HCl, hypoxanthine, and 
thymidine were obtained from Sigma Chemical Company. The other chemicals 
and their sources were; aminopterin, Nutritional Biochemicals; poly-
ethylene-glycol (molecular weight 6000), J. T. Baker Chemical Company; 
dibucaine, ICN Pharmaceuticals; orcein, G. T. Gurr; colcemid, Ciba-Giegy; 
cytochalasin D, Aldrich Chemical Company Inc.; concanavalin A conjugated 
to fluorescein isothiocyanate, Calbiochem. Dibucaine was never used 60 
days past the purchase date because ICN Pharmaceuticals would not 
guarantee its full activity. 
Cloning in Soft Agar Suspension 
Fischer's medium, buffered with either Na^HCO^ or Hepes and supple­
mented with 15% horse serum and 1% penicillin-streptomycin, was added to 
liquified-sterile agar to give a 0.2% concentration of agar. This step 
was performed in a 46°C water bath to prevent agar solidification. Three 
ml of this agar medium was added to each tissue culture tube (15 x 150 mm). 
Then the tubes were placed in a 33°C or 37°C water bath and 2 ml of 
a cell suspension in growth medium supplemented with 15% serum was added 
to each of these culture tubes. The final agar concentration was 0.12%. 
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The tubes were gently agitated and placed on ice for approximately 2.5 min­
utes (min); culture tubes were incubated at 33°C or 37°C in racks on foam 
rubber pads (Chu and Fischer, 1968). Colonies developed approximately 7 to 
10 days later at 37°C and approximately after 14 days at 33°C. Individual 
cell clones were picked with a Pasteur pipette and transferred to culture 
tubes containing 0.5 ml of growth medium to initiate suspension growth. 
Mutagenesis 
The mutagen ethyl methane sulfonate (EMS) was dissolved in phosphate 
buffered saline (pH 7.0) and added to growth medium to give a final con­
centration of 800 micrograms (yg) per ml. 2 x 10^ cells were treated at 
a cell density of 10^ cells/ml. The mutagenized cells were centrifuged 
(240 g, 10 min), washed in 40 ml of Fischer's medium without serum, and 
resuspended in fresh growth medium. Treatment times and drug-selection 
procedures are described below. 
Selection of Temperature-Sensitive Mutants 
A schematic diagram of the selection procedure for temperature-
sensitive mutants is shown in Figure 2a. The permissive temperature was 
33°C and the no npermi s s iv e temperature was 39°C. The 33°C temperature was 
regulated in an incubator that was within ±0.5°C. The 3 9 °C temperature was 
maintained within ±0.1°C in an environmental room, which is equipped with 
a sensitive thermostat and very efficient air circulation system. 
GF7 cells in logarithmic growth at 33°C were treated with EMS (800) 
yg/ml) for 24 hours. After the cells were washed free of mutagen, a sam­
ple was removed and cloned in nonselective growth medium at 33°C to deter­
mine viability (after mutagen treatment). The rest of the mutagen-
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Figure 2. Schematic diagrams of the selection procedures used to obtain dibucaine-resistant mutants: 
(a) represents the selection protocol used to isolate temperature-sensitive mutants; (b) 
illustrates a single-step selection performed at 37°C 
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treated cell population was grown for 8 days at 33°C to allow for the fix­
ation of the mutations (Cole and Arlett, 1976) and the outgrowth of 
surviving cells. During this time interval, the cell culture was rou­
tinely diluted with fresh growth medium to prevent the cell culture from 
reaching a high density. After 8 days, the cell culture was shifted to 
39°C and incubated for 24 hours to allow for the expression of the mutant 
phenotype (Basilico, 1977). Then the cells were treated at a density of 
approximately 4 x lo'^ cells/ml in growth medium containing 0.045 mM 
dibucaine for 48 hours. The selective treatment was terminated by centri-
fugation (240 g, 10 min) and washing the cells in 40 ml of Fischer's 
medium without serum. The cells were then resuspended in growth medium, 
the culture was returned to 33°C and incubated for 24 hours. After this 
time, the treated cell suspension (100 ml) was cloned in nonselective 
medium at 33°C. Approximately 14 to 17 days later, surviving colonies 
were picked and placed in 0.5 ml of nonselective growth medium. 
7 
To serve as a control, 2 x 10 nonmutagenized cells were simul­
taneously treated under identical selective conditions. 
Direct Selection of Dibucaine-Resistant 
Mutants at 37°C 
Cells from a population in logarithmic growth were subjected to EMS 
(800 yg/ml) for 15 hours (Figure 2b). After the mutagen was removed, EMS-
treated cell survival was determined by cloning in nonselective growth me­
dium. The surviving cells were maintained in suspension culture for 4 days; 
dilution with fresh growth medium was performed to prevent the cell culture 
from reaching a high cell density. After this period, cells were treated 
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4 
at approximately 4 x 10 cells/ml in 0.045 mM dibucaine for 48 hours. The 
drug-treated cells were centrifuged (240 g, 10 min), washed once in 40 ml 
of Fischer's medium without serum, resuspended in fresh growth medium with­
out drug, and incubated for approximately 18 hours at 37°C. Then the cell 
suspension (100 ml) was cloned in nonselective agar medium. Cell colonies 
developed 10 to 12 days later. As a control, a nonmutagenized cell popu­
lation was treated under identical selective conditions. 
Mutagen-Dose Response Curve 
Various concentrations of EMS were added directly to 10^ cells (10^ 
cellsVml) for 15 hours at 37''C. After each mutagen treatment, cells were 
washed once, resuspended in fresh growth medivm and maintained in suspen­
sion culture for 4 days. After this time, a sample of cells was cloned 
in nonselective growth medium to determine their cloning efficiency before 
selective treatment at each mutagen concentration. Then the cells were 
treated with selective medium (0.045 mM dibucaine) at a cell density of 
4 
approximately 4 x 10 cells/ml for 48 hours, washed once, and incubated for 
18 hours in fresh growth medium. The surviving fraction of cells was cloned 
in agar medium without drug. After 10 to 14 days, colonies developed. 
Cell Counts 
The number of cells per ml of suspension culture was determined by a 
standard electronic counter (Model ZBI, Coulter Electronics). The 
Coulter counter records both viable cells and a small minority of non­
viable cells that are within the specified size range for counting 
(450 to 3000 U^) . 
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An estimation of the true number of viable cells was made by using 
the vital stain trypan blue. An equal volume of cell suspension and try­
pan blue (0.4% in normal saline) were mixed; the suspension was pipetted 
into a hemocytometer chamber, and the cells were counted and scored for 
their color reaction. Nonviable cells incorporate the stain and, conse­
quently, are- blue in appearance, while viable cells exclude the stain. 
Studies to Determine the Toxic Effects of 
Dibucaine on Cell Growth 
Dibucaine was dissolved in distilled water with 2mM HCl at a concen­
tration of 2 mM and membrane-filter sterilized. Growth medium containing 
dibucaine (0.02 mM to 0.05 mM final concentration) was inoculated with 
4 
cells from a culture in logarithmic growth (cell density, 4 x 10 cells/ml). 
Population growth and cell viability were determined at regular intervals 
over a 3-day period. Cell counts were performed with a hemocytometer and/or 
with a Coulter electronic cell counter coupled to a P64 size distribution 
plotter. Numbers of viable cells were determined by trypan blue exclusion 
and/or by adjusting the lower size threshold of the Coulter counter so that 
all particles and cells with volumes less than 450 were eliminated from 
the total cell count. Growing cells from suspension cultures of GF7 range 
3 3 3 in size from 450 y to 3000 y (average model size 1050 y ). Viable cell 
counts determined by these two methods agreed quite well unless the drug 
concentration was cytotoxic. At cytotoxic drug concentrations, trypan 
blue determinations were more reliable because the toxic effect of the drug 
3 
restricted cell size to less than 600 y . Cells of these volumes were part 
of a size continuum which included background particles of lysed cells. 
All growth assays were repeated at least twice. 
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Also, the toxicity of dibucaine was determined by cloning cells in 
5 ml of 0.12% soft agar supplemented with various concentrations of the 
drug. Colony forming ability of the drug-treated cells was always express­
ed as a percentage of the cloning efficiency of untreated cells (control). 
4 
The growth kinetics of cells (initial density 4 x 10 cells Ail) in 
the presence of various concentrations of procaine HCl, tetracaine HCl, 
benzocaine, and ouabain were assessed over a 3-day incubation period at 
37°C. Viable cell number was determined by Coulter cell counting as 
described previously for dibucaine. Procaine HCl, tetracaine HCl, and 
ouabain were dissolved in distilled water at concentrations of 100 mM, 
10 mM, and 2 mM, respectively. These stock solutions were membrane-
filtered sterilized before addition to growth medium at the final concen­
trations. Benzocaine was dissolved in 100% ethanol at a concentration of 
1.2 molar and then added to growth medium at the final concentration. 
Polyethylene Glycol-Induced Cell Fusion 
Cell fusion was induced with polyethylene-glycol (PEG; mol wt 6000) 
as previously described (Vaughan et al., 1976). Based on the assumption 
that 1 ml of Fischer's medium weighs 1 gram (Pontecorvo, 1975; Davidson 
et al., 1976), a 50% PEG solution (weight_/weight) was prepared by adding 
Fischer's medium without serum to melted PEG. When necessary, the pH of 
this solution was adjusted to approximately 7.5 with sodium hydroxide 
(NaOH). 
7 
A total of 10 cells in logarithmic growth was harvested by centri-
fugation (2 40 g, 10 min) in a 40 ml conical tube. The cell pellet was 
resuspended in 1 ml of 50% PEG and incubated for 15 min at 37°C. At the 
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end of this period, the cell suspension was diluted by additions of 1, 2, 
4, 8, and 16 ml aliquots of serum-free medium at intervals of 1 min each. 
The cells were collected by centrifugation and the resultant pellet was 
resuspended in approximately 0.5 ml of Fischer's medium supplemented with 
50% serum. Immediately, slides were prepared for a cytological determina­
tion of fusion index (F.I.). 
Fusion index, which describes the percentage of cells that have under­
gone cell to cell fusion, was calculated by dividing the total number of 
nuclei in multinucleated cells (polykaryocytes) by the total number of 
nuclei counted. This figure was always expressed as a net figure, i.e., 
the fusion index after PEG treatment minus the background of naturally 
occurring polykaryocytes (approximately 1% to 3%). 
The number of nuclei in a given cell was determined by staining the 
cells with lacto-aceto orcein (Stadler, 1980). The PEG-treated cell 
suspension was mixed in a 4:1 ratio with stain and covered with a cover-
slip. The slide was blotted and examined. Two slides were viewed and a 
minimum of 500 cells was counted randomly per slide. 
Cell Hybridization 
5 
5 X 10 cells of a GF7 variant (TK ; dibucaine resistant) and an 
equal number of GF9 cells (HPRT ; dibucaine sensitive) were mixed and 
pelleted by centrifugation in a 40 ml conical tube. Cell fusion was 
promoted by PEG as previously described, except that cells were 
resuspended in 2 ml of Fischer's medium supplemented with '15% serum. 
This 2 ml-cell suspension was incubated 30 min at 37°C, diluted with 
5 
additional growth medium to a cell density of 10 cells/ml, and cloned 
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-4 -7 in agar medium containing hypoxanthine (10 M), aminopterin (4 x 10 M), 
-5 
and thymidine (10 M) (HAT; Littlefield, 1966). Because the GP7 variants 
are deficient in TK enzyme activity and GF9 cells are lacking HPRT 
activity, each cell line alone cannot grow on medium in which the 
endogenous biosynthesis of purines and thymidilic acid is blocked by the 
exogenous addition of aminopterin. A hybrid cell that has undergone 
fusion (e.g., GP9 with a GF7 variant) will be a functional heterozygote; 
its genetic constitution may be described as HPRT"/HPRT'*'; TK~/TK'^. This 
complementing hybrid can grow on growth medium containing HAT using 
thymidine and hypoxanthine as pyrimidine and purine sources. The products 
of homo-fusion (e.g., GF7 with GF7, and GF9 with GF9) and unfused cells 
will be selected against and eventually die. 
Hybrid colonies developed in approximately 14 days. Chromosome 
analysis was performed to verify pseudotetraploidy. 
Chromosome Analysis 
Cell cultures were prepared for chromosome analysis by a modification 
of the method by Chen (1970). A total of 5 x 10^ cells in logarithmic 
growth phase was treated for 4 hours in the presence of colcemid (0.2 \ ig/  
ml) to arrest dividing cells in metaphase. Colcemid medium was removed 
by centrifugation (240 g, 10 min). The cell pellet was resuspended by 
gentle repeated pipetting in 3 ml of a hypotonic solution (75 mM 
potassium chloride) for 8 min at room temperature. Then cells were 
centrifuged at the lowest possible speed (approximately 60 g) 
for 6 min. The supernatant was decanted, leaving approximately 
0.5 ml of hypotonic solution to resuspend the pellet by gently bubbling 
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air through a Pasteur pipette into the culture tube. In a time interval 
of 10 min, approximately 3 ml of chilled fixative (1 part glacial acetic 
acid to 3 parts methanol) was added dropwise to the cell suspension while 
gently agitating the tube. The cell suspension was slowly centri-
fuged (60g, 6 rain). Cells were resuspénded in fixative and centrifuged 
as described. Approximately 0.25 ml of fixative was left to resuspend 
the cell pellet. Two to three drops of cell suspension were added at 
different locations on a cold, wet glass slide and quickly blown to 
spread the cell preparation as widely as possible. The slides were 
air-dried (15 min), stained with aceto-orcein (20 min) (1.5 grams of 
orcein with 100 ml 65% acetic acid), destained with ethanol-HCl (1 min) 
(1 ml of 1 NHCl in 100 ml absolute ethanol), and treated for 5 min each 
with two changes of absolute ethanol. Next, the slides were air-dried 
for 10 min, and treated in two changes of xylene (5 min each). Cover-
slips were mounted with Permount (diluted 1:1 with xylene). 
Fluorescein-Concanavalin A Staining Protocol 
for Fluorescent Microscopy 
Concanavalin A (ConA) binding was detected by fluorescence using 
7 
ConA conjugated to fluorescein isothiocyanate (ConA-FITC) . 10 cells in 
logarithmic growth were centrifuged (240 g, 10 min) and resuspended in 
1 ml of Fischer's medium without serum containing 60 vig/ml of ConA-FITC. 
ConA was not washed from the cells because centrifugation resulted in cell 
agglutination, thus making examination of ConA distribution difficult. 
Therefore, 60 pg/ml of ConA was used in all experiments because this con­
centration stained the cells sufficiently but did not result in a great 
deal of fluorescent background. The cell suspension was incubated to 4°C 
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for 10 min and then shifted to 37°C for 10 or 20 min; alternatively, cells 
were treated with ConA-FITC only at 37°C for 5, 15, 25, or 35 min. A drop 
of ConA-treated cell suspension was placed on a subbed-glass slide (a 
slide coated with a 1% gelatin solution). Cells were examined immediately 
at room temperature with a Leitz fluorescent microscope (Dialux 20; 
Ploemopak illumination, filter system I) using either visible light for 
phase contrast or ultraviolet light for fluorescence. In each trial 
100 cells were examined for ConA distribution in a 5 min period. 
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RESULTS 
GF7 Sensitivity to Dibucaine 
To determine the sensitivity of the cell line GF7 to dibucaine, 
cells in suspension culture were treated during exponential growth with 
a series of drug concentrations ranging from 0.02 mM to 0.05 mM dibucaine 
at 37"C or 39®C. Starting with an initial cell density of 4 x 10^ 
cells/ml, growth rates of GF7 cells were followed for three days in the 
presence of these various drug concentrations. As presented in Figure 3, 
at 39=0 the cell population maintained exponential growth in 0.02 mM 
dibucaine; the population doubling time (Td) was 36 hours. Nevertheless, 
this growth was 3-fold slower than growth in drug-free medium where the 
Td was 12 hours. When the dibucaine concentration was increased to 0.025 
mM, the initial cell number decreased 10-fold after 3 days in medium with 
drug. At higher drug concentrations, cell death occurred approximately 
at 72 hours in 0.035 mM, 55 hours in 0.04 mM, 46 hours in 0.045 mM, and 
35 hours in 0.05 mM dibucaine. Trypan blue-excluding cells were not 
observed when the total volume of these cell cultures was centrifuged 
(240g, 10 min) and the concentrated cells were stained at the designated 
times. When cultured at 37°C in the presence of dibucaine concentrations 
that ranged from 0.02 mM to 0.05 mM, GF7 cells behaved in a similar 
manner to cells cultured at 39®C in these drug concentrations (Figure 4). 
These data helped to establish selective conditions to be used with 
the temperature-sensitive (39®C) and the single-step (37»C) methods for 
the isolation of dibucaine-resistant variant cells from wild-type popula­





Figure 3. Growth curves of GF7 at 39°C in the presence 
different concentrations of dibucaine: •, 0 mM; 0.02 mM; 
#, 0.025 mM; A, 0.03 mM; O, 0.035 mM; •, 0.04 mM; A, 0.045 mM 
0.05 mM. Viable cell number was determined by counts of 










Figure 4. Growth curves of GF7 at 37°C in the presence of 
different concentrations of dibucaine: O, 0 mM; O/ 0.02 mM; 
e, 0.025 mM; •, 0.03 mM; •, 0.035 mM; A , 0.04 mM; 0 , 0.045 mM 
0.05 mM. Viable cell number was determined by counts of 
trypan blue-excluding cells. 
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Dibucaine sensitivity also was determined examining the cloning 
efficiencies (CE) of wild-type GF7 cells as a function of drug concentra­
tion* When 100 cells per 5ml-culture tube were treated in the presence 
of 0.001 mM dibucaine, the CE (96%) was not appreciably reduced, and at 
0.01 mM the CE (63%) was decreased only 1.6-fold. A 5-fold decrease in 
CE (20%), however, was observed at 0.015 mM dibucaine, and a further 
increase in drug concentration to 0.025 mM caused a 23-fold reduction in 
CE (4%). Drug concentrations equal to or greater than 0.035 mM and 
greater totally prevented colony formation. 
Cloning experiments also showed a cell density effect on apparent 
dibucaine cytotoxicity when CE was examined as a function of the number 
of cells plated per 5ml-culture tube. The drug concentrations tested 
ranged from 0.035 mM to 0.1 mM dibucaine. At each drug concentration, a 
lower viability was observed at lower cell densities, while greater 
cell survival occurred at higher cell densities. For example, an 
4 
average number of 4 clones/5ml-tube (CE, 0.01%) was found when 4 x 10 
4 
cells/tube were cloned in 0.035 mM dibucaine. However, when 6 x 10 
cells/5ml-tube were cloned in agar medium with 0.035 mM dibucaine, cell 
survival was so great that the number of clones was impossible to count 
accurately was estimated that there were more than a 1000 colonies per 
tube. If there was no cell density effect, one would expect about an 
4 
average of 6 clones/5ml-tube when 6 x 10 cells/5ml-tube were cloned in 
0.035 mM dibucaine. The dibucaine toxicity dependence on cell density is 
further exemplified at 0.05 mM dibucaine. Complete inhibiton of growth 
was obtained when cells were treated with this level of drug at a density 
of 2 X 10^ cells/tube; but when the cell density was increased 2-fold 
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to 4 X 10 cells/tube, pin-point colonies too numerous to distinguish 
from each other developed. 
The results of these cloning experiments helped to establish the selective 
conditions for the isolation of dibucaine-resistant mutants as clones 
developing in soft agar medium containing dibucaine* 
Induction and Isolation of Dibucaine-
Resistant Variants 
Initial attempts to obtain putative drug-resistant mutants by 
cloning EMS-treated cells in selective agar medium were unsuccessful. 
Eight different mutagenesis experiments were performed. Several EMS 
doses (800 ug/ml for 14 hours; 1600 ug/ml or 1800 ug/ml for 2 hours) were 
used; after mutagenesis cell populations were maintained in fresh growth 
media without dibucaine for various periods of time (48 hours, 72 hours, 
96 hours), and then cloned in 5ml-culture tubes in various concentrations 
of dibucaine at different cell densities (2 x 10^ cells/tube at 0.04 
5 5 
mM, 0.045 mM, or 0.066 mM; 2.5 x 10 cells/tube at 0.05 mM; 3 x 10 
5 5 
cells/ tube at 0.05 mM; 3.5 x 10 cells/tube at 0.05 mM; 5.4 x 10 
cells/tube at 0.08 mM; or 5 x 10^ cells/tube at 0.1 mM dibucaine). 
The selective conditions for cloning cells in agar medivm containing 
dibucaine were based on the data from cloning experiments as previously 
described. Because a large population of cells (2 x 10^) was treated 
with mutagen to increase the chance of mutant recovery, it was not 
feasible to clone cells at low densities (i.e., densities lower than 
2 X 10^ cells/tube). Therefore, mutagenesis experiments were conducted 
5 5 
at high cell densities (2 x 10 cells/tube to 5.4 x 10 cells/tube). 
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These cell densities were plated in the lowest drug concentrations which 
would sufficiently eliminate wild-type GF7 cells. 
Failure to obtain clones in agar medium with dibucaine» ly the 
forementioned procedural variations, was later thought to be due to 
pronounced cell density effects on dibucaine cytotoxicity. Apparently, 
there were actually fewer cells capable of colony formation plated per 
tube at particular dibucaine concentrations than was determined by cell 
counting. This being so, at the drug concentrations used, a lower cell 
density «rould result in a greater effective dibucaine toxicity causing 
the elimination of both wild-type cells and putative drug-resistant 
cells. 
Because cell density influences the toxicity of dibucaine, it 
was essential to control the number of cells plated per ml in soft agcir 
with dibucaine as accurately as possible. After EMS-treated cells were 
cultured in suspension under nonselective conditions for 48 hours to 96 
hours (expression period), the percentage of viable cells per ml of 
suspension culture was determined by trypan-blue staining and cell 
counting using a hemocytometer. This percentage was used to estimate the 
number of EMS-treated cells to be pipetted to each 5ml-culture tube 
containing agar medium with dibucaine. Cytologically determined cell 
viability was later found to be an inaccurate reflection of the cloning 
ability of EMS-treated cells because the additional physical stress of 
cloning in soft agar is more severe for EMS-treated cells than for 
non-EMS treated cells. For example, in a nonmutagenized culture of cells 
the CE is generally 80% to 90% of the cytologically determined cell 
viability; conversely, cloning EMS-treated cells at the end of the 
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expression period for "expression survival" showed a CE of about 30% of 
the cytologically determined cell viability. 
Because the atten^ts to recover dibucaine-resistant cells by cloning 
in the drug were unsuccessful, other mutant selection schemes were 
devised that did not involve cloning in the presence of dibucaine. These 
methods were a temperature-sensitive selection at 39"C emd a direct 
selection at 37*0, both of which involved a short term selective pulse 
(48 hours) of a high dibucaine concentration (0.045 mH) in suspension 
culture followed by cloning for drug-surviving cells in nonselective 
medium (Figure 2). Treatment time and dibucaine concentration were taken 
from data pertaining to growth of wild-type GF7 cells in suspension (see 
Figures 3 and 4). 
Selection of temperature-sensitive 
mutations to dibucaine resistance 
It has been shown previously that dibucaine adversely affects many 
fundaunental cell functions involving interactions of basic cell structures 
including membrane proteins, lipids, and cytoskeletal structures (Seeman, 
1972; Richards, 1978; Nicolson et al., 1976). Therefore, it seemed 
possible that a selected inability to respond normally to the toxic 
effects of the drug might result from alterations in basic cell structure 
and that these alteration might, in turn, be growth inhibiting or lethal. 
For this reason, a ten^erature-sensitive (ts) selection method (Basilico, 
1977) was used to attempt to recover variant cells that would display 
conditional dibucaine resistance, i.e., expression of the defect under 
one environmental condition only. 
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As described in Materials and Methods (Figure 2a), 33°C was used as 
the "permissive temperature", where cell function is normal, and 39®C was 
used as the "nonpermissive" temperature, where cells might display 
resistance to the cytotoxic effects of dibucaine. EMS treatment with 800 
ug/ml for 24 hours resulted in a high percentage of cell killing (5.8% 
relative survival; Table 2). Cells were grown for 8 days at the permis­
sive temperature (33°C), and then shifted to the nonpermissive temperature 
(39»C) for 3 days. During this 3-day time period, cells remained in 
drug-free medium for 24 hours to allow for expression of presumptive 
heat-labile cell components (e.g., proteins) and was followed by a 
48-hour treatment with 0.045 mM dibucaine. Clones did not develop from 
the control population of 2 x 10^ nonmutagenized cells under identical 
selective conditions. In this instance, negative selection was complete. 
The EMS-treated population, however, gave rise to 20 clones (frequency 
-5 1.73 X 10 ; Table 2). These clones were picked, placed in 0.5 ml of 
nonselective me dim, and grown in suspension at 33°C. 
The temperature-sensitive nature of these clonal isolates was then 
determined by investigating the following alternative hypothetical 
cellular idienotypes: (i) cells have a temperature-sensitive alteration 
that yields dibucaine resistance and that also limits cell growth at 
39»C; (ii) cells have a heat-sensitive alteration that confers dibucaine 
resistance at 39®C without interfering with normal cell growth at that 
temperature; (iii) cells are not temperature-sensitive for dibucaine 
resistance or growth in spite of selection at 39°C. 
To determine if dibucaine resistance is accompanied by growth 
failure at the nonpermissive temperature, the growth rate of the 20 
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Table 2. Frequency of clones surviving after a 48-hour treatment with 













37 °C selection 
800 yg/ml, 24 hours 
0° 
800 yg/ml, 24 hours' 
0 
800 yg/ml, 15 hours 
0 
1.73 X 10 
0 
4.7 X 10 
0 











Calculated as: (number of surviving clones induceti with mutagen) / 
(2 X 10^ cells mutagenized) (relative survival). 
^Calculated as: (cloning efficiency of cells immediately after EMS 
treatment/(cloning efficiency of untreated cells). 
c 7 
Control population of 2 x 10 cells selected under identical 
selective conditions as the no mutagenized cell population. 
"^The temperature sensitive isolation procedure was repeated to 
determine the reproducibility. 
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clonal isolates was measured at 39®C. The cells derived from the 
temperature-sensitive selection displayed exponential growth similar to 
the parental line in drug-free medium. The doubling time of the parent 
line GF7 was 13 hours, and the Td of the ts clonal isolates ranged 
from 13 hours to 15 hours. This indicates that the 20 isolates do not 
have an alteration that significantly interferes with cell growth or 
division at 39®C. 
The growth response of these clonal isolates in the presence of 
dibucaine at 39®C was also determined. Although 0.045 mM dibucaine was 
the selective drug concentration for the 48-hour killing pulse following 
mutagenesis, 0.025 mM drug was routinely used to assess drug resistance 
in 3-day growth assays. This latter drug concentration allowed most 
drug-resistant cells to grow exponentially, but caused extensive cell 
death in wild-type GF7 cells. Nevertheless, when drug-resistant cells 
were exposed to 0.045 mM dibucaine, they survived but did not exhibit 
population doubling during a 3-day growth assay (see Figure 7b). 
As shown in Figure 5, the level of drug resistance differed among 
the 20 ts isolates at 0.025 mM dibucaine. Sixteen sublines maintained a 
Td of 22 hours to 50 hours, and four sublines did not increase or decrease 
in viable cell number after three days of drug exposure. Because 20 
sublines would be difficult to illustrate in a single figure. Figure 5 
depicts only 8 of the 20 sublines to clearly demonstrate the observed 
variability in drug resistance. Two of the 20 sublines that maintained 
the shortest population doubling time in the presence of 0.025 mM dibucaine, 
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Figure 5. Growth of GF7 (•) and ts isolates in medium 
plus 0.025 mM dibucaine at Cell number was followed 
with a Coulter cell counter. Only 8 out of the 20 Dib^ isolates 
are depicted. 
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and Dib -10) are not depicted in Figure 5, but their growth response in 
dibucaine medium is presented in Figure 6. 
Drug resistance to 0.025 mM dibucaine was tested at 33°C, 37°C/ 
and 39°C to determine if the drug resistance exhibited by Dib -5 and 
Dib -10 was expressed only at the 39°C nonpermissive temperature 
(Figure 6). After three days at 33»C, the Dib -10 population had 
increased 5-fold in cell number; at the same time, the parental population 
(GF7) had decreased 2.5-fold in cell number (Figure 6). Because the 
R 
Dib -10 cell population displayed resistance at the permissive tempera­
ture (33°C), it was concluded that the dibucaine-resistant phenotype of 
the Dib -10 subline is not restricted by temperature. In addition, the 
Dib -10 variant population displayed a Td of 26 hours at 37°C, and a 
Td of 24 hours at 39°C in the presence of 0.025 mM dibucaine. These 
population doubling times are similar to the growth rate observed at 
33»C (Td = 26 hours). 
The possibility exists that the dibucaine-resistant property of 
R 
Dib -5 may be he at-dependent because exponential growth in the presence 
of 0.025 mM dibucaine occurred only at 37°C (Td = 18 hours) and at 39°C 
p 
(Td = 22 hours), but not at 33°C (Figure 6). At 33°C, Dib cell 
4 
numbers remained stationary at 4 x 10 cells/ml, the initial inoculum. 
The parental cell population declined in cell number during three days of 
dibucaine e}q)osure at all three temperatures. 
R R 
For ease of culturing, and because Dib -5 and Dib -10 exhibited 
drug resistance at 37»C, both Dib^-s and Dib^-lO cell lines were 
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Figure 6. Growth of GF7, Dib -5, and Dib -10 in medium plus 0.025 mM dibucaine 
as a function of temperature; #—•, 33°C; A—A, 37°C; O—0, 39°C. Increase or 
decrease in cell number as function of time was followed with a Coulter cell 
counter. 
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Materials and Methods)* These varlêmt sublines maintained normal growth 
R R 
In nonselective medium (Dlb -5/ Td = 11 to 13 hours; Dlb -10 Td = 12 
to 14 hours)* 
Single-step selection in suspension 
culture at 37*C 
The fact that the ts Isolate, Dlb -10, displayed dibucalne resistance 
at the nonpermlsslve ten^erature (33*C) showed that it was unnecessary 
to use a conditional selection system to obtain variants with a dibucaine-
reslstant phenotype* To further establish this point, dibuccdjae-resistant 
variants were selected at 37*C in a single-step. The 37*>C selective 
conditions were Identical to those of the tengperature-sensitlve scheme, 
i * e *, desired variants were Isolated by treating mutagenlzed cells with a 
high concentration of dibucalne (0.045 mM) for 48 hours (Figure 2b). In 
a control population of 2 x 10^ non-KMS treated cells, 10 clones 
survived this pulse-drug treatment (frequency 5 x 10 Table 2). 
These clones were picked and tested for drug resistance by growth in 
suspension in the presence of 0.025 mM dibucalne. 
Subpopulations of these ten clonal Isolates were reduced 9.3- to 
19-fold in cell number after 3 days in growth medium with 0.025 mM 
dibucalne. At the Scune time, wild-type GF7 cells showed a 17-fold 
decrease in cell number. The observed decreases in cell number was 
interpreted to mean that these survivors were not spontaneous Dlb 
variants, but apparently orglnated from cells which had singly escaped 
killing in the selective medium. 
4 Mutagenesis and selection yielded 243 clones from 6 x 10 viable 
cells plated. The variant frequency was 4.05 x 10 ^ (Table 2). Twenty 
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of the 243 clones were isolated at random and tested for their response 
to 0.025 mM dibucaine. All 20 clonal isolates exhibited variable drug 
resistance, similar to the ts isolates. Cell populations from 18 clonal 
isolates maintained population doubling times that ranged from 18 to 52 
hours in the presence of 0.025 mM dibucaine. Two clonal isolates were 
found to decline 2-fold in cell number after three days of drug treatment. 
Nevertheless, these two clonal isolates were still considered to be more 
drug tolerant than the parent cell line, which was reduced 22-fold in 
cell number after three days in culture. Of the 20 isolates, the two 
most drug-resistant sublines were used for further studies and designated 
R R R 
Dib -1 and Dib -7. Dib -1 cells showed a Td of 18 hours and 
Dib^-7 demonstrated a Td of 25 hours in 0.025 mM dibucaine at 37°C 
(Figure 7a). 
R R R 
Soon after the the isolation of Dib -1, Dib -5, Dib -7, and 
R 
Dib -10, they were tested for growth in the presence of the selective 
drug concentration, 0.045 mM dibucaine. Population growth did not occur 
during a 3-day period (Figure 7b). Only slight decreases (< 4-fold) in 
cell number were observed during this time. In contrast, extensive cell 
death occurred in the parental cell population. 
All four lines, Dib^-1, Dib^-5, Dib^-7, and Dib^-10, were 
cloned again in drug-free medium to ensure phenotypic homogeneity. All 
variant lines were pseudodiploid and remained so for the duration of this 
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Figure 7a. Growth of ( A ) GF7, (•) Dib -1, and (O) Dib -7 
in medium plus 0.025 raM dibucaine at 37°C. Cell number 
determined as in Eigure-3. 
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time (hours) 
Figure 7b. Growth curves of dibucaine-resistant (Dib ) variants 
in the presence of the selective drug concentration, 0.045 mM 
dibucaine. Dib^-5 (•—#) and Dib^-10 (•—•) , derived from the tempera­
ture-sensitive selection, were tested at 39°C. Dib^-l (0—0) and 
Dib^7 (Jf—A) , derived from single-step selection at 37"C, were tested 
at 37*C. The parent GF7 line is (•—• ) at 39°C and (A—A) at 37°C. 
Viable cell number was determined as in Figure 3. The Td's for these 
cell lines were: GF7, Td = 12 hours at 37°C, and Td = 14 hours at 
39°C; Dib^-5, Td = 14 hours at 39°C; DibR-7, Td = 12 hours at 37°C. 
in drug^free medium. 
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Expression time 
Expression time, the length of subculture in nonselective medium 
after mutagen treatment# is an important factor in the subsequent 
detection of variant clones. The influence of this time interval on the 
recovery of putative dibucaine-resistant clones was determined. The data 
in Figure 8 reveal a correlation between increased expression time and 
increased recovery of drug-surviving variant clones induced by mutagen, a 
correlation that has been noted in other laboratories (Hsie et al.,1975; 
Friedrich and Coffino, 1977; Penman and Thilly, 1976; Cole and Arlett, 
1976). As shown in Figure 8, no colony formation occurred when cells 
were maintained in nonselective medium for 24 hours after EMS treatment, 
but before drug selection. When the expression interval was increased to 
4 
48 hours, a small number of clones (6 clones/10 survivors) was detected. 
After longer expression periods the number of presumed dibucaine resistant-
clones increased; this increase was approximately 5-fold at 72 hours cuid 
17-fold at 96 hours. These data demonstrated that dibucaine-surviving 
clones cannot be detected until a 48-hour expression period. This 
differs from ouabain resistance (Qua ) where Oua variants of L5178Y 
mouse lymphoma cells can be recovered by cloning in ouabain immediately 
after EMS treatment with the maximal induced frequency occurring at 24 
hours (Cole and Arlett, 1976). 
If the data in Figure 8 are plotted as the log "number of drug-
surviving cells" against linear "expression time", they fit a straight 
line. The slope of this line would represent a 12-hour population 
doubling time when a simple increase in cell number is plotted against 
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Figure 8. The effects of expression time on the recovery of putative 
Dib^ variant clones derived from GF7 cells. EMS (600 ug/ml) was added to 
4 parallel cultures, each containing 4 x 10® cells (10^ cells/ml), for 15 
houro at 37°C. After the mutagen was removed, these cell cultures wore 
maintained in nonselective medim for the specified lengths of time 
(24 hours, 48 hours, 72 hours, and 96 hours). The cells were then 
exposed to 0.045 mM dibucaine for 48 hours at 4 x 10^ cells/ml. Drug 
medium was replaced with nonselective medium and the remaining cells 
were incubated for 18 hours before cloning in nonselective medium. The 
variant frequency was determined as: (the total number of clones 
surviving dibucaine selection) /(% "expression" survival at 600 pg/ml 
EMS). The "expression" survival (i.e., the percentage of cells surviving 
EMS treatment at the end of the expression time) was 0.12% at 24 hours, 
0.38% at 48 hours, 1.1% at 72 hours, and 1.3% at 96 hours. In addition, 
the population growth (total number of cells) was followed during the 
expression intervals and determined by Coulter cell counting. 
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increase in the number of drug-surviving clones at each expression 
interval could simply reflect normal population growth. 
Nevertheless, after EMS treatment with 600ug/ml for 15 hours, 
substantial cell killing occurred with no appreciable increase in the 
population rate of these EMS-treated cells (Figure 8)« After the 4-day 
expression period, the treated cell population had increased only from 
6 6 
4 X 10 cells to 7.4 % 10 cells. Although gross population growth 
was negligible, the possibility exists that dibucaine-resistant cells 
divided at a normal rate (i.e., at a Td of 12 hours), while the growth 
of wild-type cells in the popoulation was affected during the expression 
period after the previous exposure to mutagen. 
This phenomenon of normal growth of variant cells and reduced growth 
of wild-type cells is not very likely because evidence provided by other 
researchers has indicated that the growth of variant-type cells is less 
than wild-type cells (Shapiro et al., 1970; Cole and Arlett, 1976; Duncan 
and Brookes, 1973; Arlett and Harcourt, 1972). These studies showed that 
when the maximal number of variant clones was detected, the variant 
frequency decreased with excessively long expression periods. It was 
suggested that this decrease represents the selective loss of variant-type 
cells because their growth was less than wild-type cells. 
Because expression periods beyond four days were not tested, the 
expression time that allows for the maximal production of putative Dib 
variants, and the time when the number of variant clones drops off is not 
known. For example. Cole and Arlett (1976) observed that the highest 
frequency of thymidine-resistant variants of L5178Y cells occurred 4 days 
after EMS ejtposure, and after 6 days the variant frequency decreased. 
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However, the number of 6-thioguanine-resistant variants induced by EMS 
treatment peaked at 8 days and diminished thereafter. 
Initial Characterization of the Dibucaine-
Resistant Phenotype 
Initial characterization of Dib^ variant sublines included tests 
of growth response to different concentrations of dibucaine, and tests of 
cross resistance to other local anesthetics and ouabain, a membrane-
active drug. Also, plasma membrane fusion ability and the lateral 
movement of concanavalin A (ConA) receptors at the cell surface were used 
as f^ysiological assays to determine the existence of phenotypic classes 
other than drug resistance. These physiological screens were chosen 
because dibucaine has been reported to inhibit both cell fusion and 
capping of ConA receptors (Poste and Reeve, 1972; Poste et al., 1975b). 
This being so, it was speculated that the dibucaine resistant phenotype 
could be associated with an inability of cell surface receptors to cap 
normally and/or an altered fusion competence. 
It was anticipated that the data of these initial tests could be 
used to direct future biochemical studies. For example, failure to 
induce capping with ConA might suggest a diminished membrane fluidity or 
an alteration in cytoskeletal structures. 
To reveal different subclasses of the Dib phenotype, at least two 
of the four variant sublines (Dib^-1, Dib^-5, Dib^-7, Dib^-10 ) 
were randomly included in each different test, except for the examination 
of ConA distribution where only one variant subline was tested. 
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Growth response In the 
presence of dlbucalne 
Dlb*-1, Dlb^-5/ Dlb^-7/ and Dlb^-10 which were selected as 
survivors of 0.045 mM drug treatment for 48 hours, were examined at 37*0 
for survival and growth In the presence of dlbucalne concentrations that 
ranged from 0.02 mM to 0.03 mM for 3 days (Figure 9). Least-squares 
linear regression analyses were performed using data derived from the 
linear portion of the growth curves (logarithmic cell growth was plotted 
against time), and slopes were determined. If a lag In growth occurred, 
those polnt(s) were eliminated from the linear regression. The slope of 
the line Is defined as a specific growth constant, K, which Is representa­
tive of population growth since the doubling time of the population (Td) 
Is described by the equation: 
A positive K Is Indicative of a growing cell population; a negative 
K denotes that most of the cells have stopped dividing and are lyslng, 
for exeunple because of the cytotoxic effects of a drug, as In this 
case. 
As seen from the data presented in Figure 9, cell population of 
R R R R 
Dlb -1, Dib -5, Dlb -7, and Dib -10 demonstrated some level of 
exponential growth in all three drug concentrations tested. The Td for 
the variants ranged from 17.6 to 21.5 hours (K = 0.039 to 0.032) at 
0.02 mM dlbucalne, 20 to 25 hours (K = 0.035 to 0.028) at 0.025 mM, 25 to 
41.5 hours (K = 0.028 to 0.016) at 0.03 mM dlbucalne. In contrast, the 
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Figure 9. The growth constant of (•) wild-type GF7 cells 
(O) DibR-1, (P) DibR-5, (A) DibR-7, and (A) Dib^-10 as a 
function of dibucaine concentration. Calculation of growth 
constant is .explained in Results. Cell number determined as 
in Figure 3. 
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the lowest drug concentration tested (0.02 mM dibucaine). At higher drug 
concentrations (0.025 mM and 0.030 mM), GF7 cells progressively died. 
Therefore, all Dib variant sublines displayed a drug resistance 
greater than the parental line. 
R R 
To further test the Dib phenotype expressed by Dib -5 and 
Dib -10, cells were cloned at various concentrations of dibucaine 
(Table 3). At 0.01 mM dibucaine, the two variant cell lines exhibited a 
relative cloning efficiency 6- to 7-fold greater than the parent.' At 
0.015 mM dibucaine, colony formation in the wild-type parent line was 
completely inhibited, while the cloning efficiency of Dib -5 variant 
decreased only about 2-fold and the cloning efficiency of Dib -10 
decreased 4-fold. Growth was completely suppressed when either parent or 
variants were plated in 0.02 mM dibucaine. The absolute dibucaine 
R R 
resistance displayed by Dib -5 and Dib -10 was less in soft agar than 
in liquid suspension. 
Cross resistance to other 
local anesthetics 
Dibucaine is an aromatic amine which belongs to a group of local 
anesthetics that produce similar effects on a variety of membrane proper­
ties. Included in this group are tetracaine, procaine, and benzocaine 
R (Table 4). The growth response of the Dib variant sublines was 
compared to growth of the parental cell line, GP7, in growth tests with 
these latter anesthetics to determine if there is a specificity of 
resistance to dibucaine only. The series of drug concentrations tested 
were those that elicited responses ranging from exponential growth to 
cell death in the parent cell line. As shown in Figure 10a, the Dib 
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Table 3. The cloning efficiencies of parent cell line and Dib 
variants as a function of dibucaine concentration at 37 °C 
Relative cloning efficiency ^  
Cell line 0.01 mM dibucaine 0.015 mM dibucaine 0.02 mM dibucaine 
GF7 13.1 ± 3.25 0 0 
Dib*-5 90.45 ± 3.04 48.6 ± 9.96 0 
Dib^-10 83.0 ± 2.83 18.65± 5.16 0 
^Each cloning efficiency (CE) is expressed as a percentage of the CE 
of untreated cells and represents the mean ± standard deviation of two 
experiments. In each experiment, a single CE determination was derived 
from the mean colony count of 5 tubes. The cells were cloned at 100 cells 
per tube. 
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tetracaine (mM) procaine (roM) benzocaine (mM) 
Figure 10. The dibucaine-resistant lines (A—A, Dib^-1) , (#—9, Dib^-5) , 
^ f Dib^7), (O—O, Dib^-10>,and the parent cell line (•—O, GF7) were grown in 
the presence of other local anesthetics. Cell number was followed for 3 days with a 
Coulter cell counter. The growth constant was determined as in Figure 9. 
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sublines were cross resistant to tetracaine. All four Dib variant 
populations maintained exponential growth at tetracaine concentrations of 
0.15 mM (Td ranged from 15 to 17 hours), 0.2 mM (Td ranged from 17 to 23 
hours), 0.25 mM (Td ranged from 23 to 32 hours), and 0.3 mM (Td ranged 
from 28 to 35 hours) as indicated by positive K values at each of these 
drug doses. In the presence of 0.2 mM tetracaine, the parental cell 
population doubled at a slower rate (Td = 39 hours) than the variant 
sublines, and responded with a pronounced decline in cell count (negative 
K) at tetracaine concentrations greater than 0.2 mM. 
Conversely, these variant sublines were not cross resistant to 
either procaine or benzocaine; the growth response of the Dib variant 
populations to these drugs was like that of the drug-sensitive GF7 
population (Figure 10b and c). 
Effects of ouabain on the growth 
of dibucaine-resistant variants 
The steroid ouabain blocks the Na^/K* transport system by 
inhibiting the membrane enzyme Na /K /Mg -activated ATPase 
(Baker et al., 1974). Because it has been shown that the local anesthetic 
^ 2+ 
tetracaine inhibited Na /K /Mg -activated ATPase activity in 
human erythrocytes (Bond and Hudgins, 1976), and because the local 
anesthetic dibucaine has been reported to interfere with ouabain uptake 
in liver cells (Graf and Peterlik, 1976), it was thought that dibucaine 
+ + 2+ 
resistance may be associated with an altered Na /K /Mg -activated 
ATPase activity. A modification of this enzyme may also prevent functional 
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Figure 11. Growth rate of wild-type GF7 cells (A) , Dib -5 (•), and 
Dib®-10 (•) as a function of ouabain concentration at 37"C. Growth 
constants were determined as in Figure 9. Cell number was followed for 
3 days with a Coulter counter. 
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variants to ouabain may indicate an altered Na /K /Mg -activated 
ATPase. 
The effect of ouabain was examined in terms of growth response of 
R R 
the Dib -5 and Dib -10 variant cell populations to various concen­
trations of this membrane active drug (Figure 11). No appreciable 
difference between the growth rate of parent cells and the growth rate of 
Dib variant cells in response to increasing concentrations of ouabain 
was observed. 
Plasma membrane fusion ability 
of Dib -5 and Dib -10 
Because dibucaine has been shown to inhibit plasma membrane fusion 
between cells (Poste and Reeve, 1972), it was of interest to test the 
fusion ability of two Dib* variant sublines. If drug resistance is the 
result of either a reduced binding of dibucaine or an altered response of 
bound dibucaine to a modified structure that was also involved in plasma 
membrane fusion, then dibucaine resistance may be accompanied by an 
altered fusion competence* 
Plasma membrane fusion competence was tested in Dib -5 and 
Dib -10 and assessed in terms of cell to cell fusion stimulated 
by the chemical polyethylene glycol (PEG). As shown in Table 5, the 
acquisition of dibucaine resistance in Dib -5 did not alter its cell 
fusion ability. Variants responded only with a 1.26-fold lower fusion 
Table 5 . Cell fusion competence: a comparison of two dibucaine-resistant isolates with the 
parent cell line GF7 
Cell Lines 






















1 28.5 38.0 28.6 47.3 11.0 34.0 
2 31.3 60.0 34.3 17,6 19.8 29.0 
3 30.0 48.0 14.5 28.0 15.2 41.6 
4 35.2 26.3 21.8 32.4 17.8 35.8 
means 
d 
± s 31.3 ± 2.9 43.0 ± 8.6 24.8 ± 8.6 31.3 ± 12.3 16.0 ± 3.8 35.1 ± 5.2 
a 
Separate trials were performed on different days . 
b 
Cell fusion was promoted by PEG at 37°C as described in Materials 
1,000 cells were scored for each determination of net fusion index (i.e. 
treatment minus the background fusion index of the untreated cells). 
and Methods. 
, the fusion 
A minimum of 
index after PEG 
ë 
o 
The viability of the treated cells was expressed as a net percentage (i.e., the viability of un­
treated cells minus the viability of PEG treated cells) and trypan blue exclusion immediately after PEG 
treatment. _ 
d — — 
The mean (X) of the 4 trials was calculated as: X = £ X^/n, and the standard deviation(s) of 
the samples was calculated as: , i = 1 
rJJ- nX^)/(n-l) 
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Index than the parent cell line GF7; a negligible difference ^(t = 
1.43; p > 0*05). Dib -10 variant cells, however, demonstrated a 2-fold 
reduction in fusion ability compared with GF7. This is a slight difference, 
but is statistically significant (t = 3.21; p < 0.05). 
Several physical pareuneters, such as temperature, pH, and cell 
density, have been demonstrated to influence the extent of cell to cell 
fusion induced by PEG in GF7 cells (Vaughcui et al., 1976). Although 
these variables were controlled in this study, it is not possible to 
strictly regulate cell growth, which has been shown to strongly influence 
the fusion ability of GF7 cells (Figure 12). Cells populations with a 
slower doubling time fuse to a lesser extent than cells that multiply 
faster. As depicted in Figure 12,the fusioi index for wild-type GF7 
cells ranged from approximately 21% to 26% at a Td of 12 hours, while 
fusion indices of 13% to 19% were observed at a Td of 14 hours. The 
Dib -10 cell population maintained a Td of 14 hours, 2 hours slower 
than the GF7 population (Td = 12 hours). 
This 2-hour difference could explain the observed 2-fold reduction 
in fusion index in the Dib -10 variant, if the variation in fusion 
index observed at a particular Td is considered. For example, a 26% 
fusion index was observed at the upper end of the range for a Td of 
12 hours, and a 13% fusion index was seen at the lower end of the range 
The_sign^ficance of variance was determined by a student's t test 
(t = X_ - X^/S—) at a significance level of p =» 0.05; p is the 
probability that the difference observed between the mean fusion index 
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Figure 12. The correlation between fusion index and doubling time of 
the cell line GF7. Fusion was induced by polyethylene glycol (mw 6000) and 
fusion indices were derived from separate trials. The linear curve was 
constructed by a least-squares method. 
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for a Td of 14 hours (Figure 12). Thus, a 2-hour difference in Td can 
result in as much as a 2-fold reduction in the observed fusion index of a 
cell line. 
Redistribution of concanavalin A 
receptors 
Capping of cell surface receptors involves changes in the redistri­
bution of membrane glycoproteins. They move laterally in the plane of 
the membrane bilayer under the transmembrane control of cytoskeletal 
structures, e.g., microfilaments and microtubules (Edelman, 1976). 
Dibucaine has been shown to inhibit capping induced by the plant lectin 
concanavalin A (ConA), presumably by disrupting the mi cr of il ament-mi cro-
tubular system (Poste et al., 1975b). The distribution of ConA receptors 
was examined in a Dib variant to determine if dibucaine resistance was 
correlated with changes in the binding of ConA and the lateral movement 
of these cell surface protein receptors. 
GF7 parental cells were exposed to fluorescein-labeled ConA (fl-ConA) 
for various times at 37*C. Several ConA labeling patterns were observed 
by fluorescent microscopy (Table 6). After a 5 min incubation at 37«»C, 
the majority of cells (75%) were stained diffusely and uniformly; 20% of 
the cell population exhibited patched fluorescence. However, after a 15 
min ConA incubation at 37®C, 22% of the total cell population displayed a 
caplike pattern with label brightly concentrated over a small portion of 
the cell. In a small percentage of cells (4%), fluorescence was distrib­
uted over a cellular uropod. Longer incubations at 37°C (25 min and 35 
min) resulted in the majority of cells (53%, 56%) having fluorescence 
brightly associated about their periphery as a halo. The ConA induced-
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Table 6. Redistribution of concanavalin A (ConA) in GF7 cells and 
DibR-10 cells 
ConA staining pattern^ 
(% of total population) 
ConA treatment Uniform Halo Patches Cap Uropod 
Cell line (60 yg/ml) Cap 
GF7 37°C,^ 5 min 75 1 20 3 1 
15 min 63 4 7 22 4 
25 min 56 18 4 17 5 
35 min 53 34 1 4 a 
Dib*-10 37 °C, 5 min 78 0 18 2 2 
15 min 63 3 9 19 6 
25 min 54 8 10 20 8 
35 min 51 31 3 5 10 
GF7 4°C 37°cf 
10 min 61 1 13 21 4 
20 min 56 3 10 24 7 
Dib^-10 4°C 4- 37°C 
10 min 56 3 15 18 8 
20 min 52 4 12 22 10 
a 
The scoring of staining pattern was used as an evaluation of the 
distribution of fluorescence about the cell. Five different patterns were 
observed and are described in detail in the Results. One hundred cells 
were counted for each procedural variation tested. 
^A population of cells in logarithmic growth was exposed to 60 lag/ml 
of fl-ConA for various times at 37°C. 
^ A cell population chilled to 4°C was treated with fl-ConA for 10 min 
at 4°C and then shifted to 37°C for 10 or 20 min. 
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capping reaction of Dib -10 variant cells was similar to GF7 at the 
various time treatments (Table 6). 
An alternative method of ConA-induced capping, which involved a cold 
shockI was used to determine if differences between Dib -10 cells and 
parent cells could be detected. Cells were treated with ConA for 10 min 
at 4®C and then shifted to 37"C for 10 min or 20 min (Schreiner and 
Unamue, 1976; Ryan et al*/ 1974). This cold shock did not alter the 
R 
capping response of either GF7 cells or Dib -10 variant cells (Table 
6). Again, no significant difference in ConA distribution was observed 
between GF7 cells amd Dib -10 variant cells. These data indicate that 
mobilization of bound ConA into a cell surface cap was not altered or 
impeded in the Dib -10 variant. 
Genetic Analysis of Dib Variants 
To investigate the question of whether the Dib variants are 
"true" genetic mutants, the stability of the variant phenotype, the 
effects of mutagen exposure on the frequency of cells surviving dibucaine 
selection, and the expression of dibucaine resistance in somatic cell 
hybrids formed between drug sensitive and resistant cells were examined. 
The results of these studies indicated that dibucaine resistant cells 
arise following gene mutation. 
Phenotypic stability 
After isolation, Dib^-1, Dib^-5, Dib^-7, and Dib^-10 cells 
were tested once a month for the stability of their dibucaine resistant 
phenotype. As shown in Figure 13, the level of resistance to 0.025 mM 
dibucaine displayed by variant cell populations was not altered after 
106 
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Figure 13. The stability of the dibucaine-resistant phenotype 
of the DibR variants (•, Dib^-l; Q, Dib^-5; O, Dib^-?; a, DibR-iO), 
and the sensitivity of the parental cell line ( A, GF7) as a func­
tion of time in continuous nonselective culture. Growth constant 
(K) was determined as described in Results (page 91 ). The 
phenotype was assayed by measuring the growth rate in the presence 
of 0.025 mM dibucaine for 3 days- Cell number was. determined by a 
Coulter cell counter. 
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many months of serial subculture under nonselective conditions. Dib -5 
R R 
and Dib -10 cells were in continuous culture for 11 months, and Dib -1 
and Dib -7 cells for 7 months. This observed stability is consistent 
with attributing dibucaine resistance to a mutational event and indicates 
that the Dib^ variants do not revert to the parental phenotype at 
an inordinately high frequency. Because no clear selection system exists 
for the isolation of individual dibucaine-sensitive revertants, the 
reversion frequency and the effect of mutagen treatment on this frequency 
R 
was not determined for the Dib isolates. 
Although the dibucaine-resistance phenotype exhibited by variant 
cell populations behaves as a stably heritable trait, some minor phenotypic 
variation was observed among subclones derived from these variant lines. 
(Table 7). This was determined by cloning variant cells in nonselective 
medium after an extended period of time in continuous subculture in 
drug-free medium. Five subclones were picked randomly from each Dib 
variant line, grown in the absence of dibucaine, and then tested for 
resistance to 0.025 mM dibucaine for 3 days in suspension culture. As 
indicated in Table 7, the phenotypic variation exhibited among subclones 
was small. The population doubling times in the presence of drug among 
the subclones derived frcan the four Dib variant lines only varied over 
a 1.3- to 2-fold range. For example, the Td of subclones of Dib -10 
cells ranged from 23 hours to 48 hours. Nevertheless, all of these 
subclones were more drug resistant relative than the 5 subclones of 
wild-type GF7 cells, which were reduced in cell number 20-fold after 3 
days in 0.025 mM dibucaine. 
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Table 7. Range of phenotypic variation among subclones derived from 
Dib^ variant lines. 
^Population doubling times (hours) in the 
presence of 0.025 mM dibucaine 
Variant and 
parental cell 
lines 1 2 
Subclones 
3 4 5 
Dib^-1 21 28 22 23 44 
Dib^-5 26 25 21 22 32 
Dib^-7 20- 24 23 26 25 
Dib^-10 23 48 24 26 23 
^GP7 0 0 0 .0 . 0 
and Dib^-10 subpopulations were cloned in drug^feee medium after 
8 months of continuous subculture in dibucaine-free medium, and Dib^l and 
Dib^7 after 4 months. Five subclones were picked at random. After the 
initiation of suspension growth, cell populations of these subclones were 
treated with 0.025 mM dibucaine for 3 days at 37"C. The population 
doubling times of these subclones in drug-free medium were 11 to 13 hours 
for the subclones derived from Dib®-1/ -5, and -7 and 12.5 to 15 hours for 
subclones of Dib®-10. Viable cell number was determined by trypan blue 
exclusion. 
^Populations subclones, derived .from, wild type GP7 cells included x» 
detectable viable cells after 3 days in medium with 0.025 mM dibucaine. 
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Such variation among subclones of a drug resistant cell line is not 
uncommon* For exan^le, differences in the resistance exhibited by 
subclones derived from ouabain resistant (Oua ) mutants has been 
described Baker and coworkers (1974). The relative plating efficiencies 
at a marginally toxic ouabain concentration varied over a 100-fold range 
among subclones derived from a Oua mutants from mouse L cells, and a 
1.8-fold range among subclones of another Oua mutfmt line from L cells. 
Phenotypic Vcuriation may be the result of karyotypic heterogeneity. 
EMS concentration versus induction of 
dibucaine-resistant variant clones 
In a variety of selective systems (e.g., 6-thioguanine, ouabain, 
and dibutyryl adenosine 3': 5'-cyclic monophosphate), the frequency of 
drug-resistant mutations has been shown to be a function of mutagen 
concentration (Friedrich and Coffino, 1977; Hsie et al., 1975). The 
interpretation of these findings is that drug resistance resulted from 
DNA base changes induced by mutagen treatment. To further examine the 
hypothesis that resistance to dibucaine might be genetically based, the 
relationship between mutagen concentr ation and the frequency of drug-
surviving clones was examined by using the dibucaine-selection system at 
37"C. These results are presented in Figure 14. 
The cell killing effects of EMS treatment were not determined 
immediately after mutagen treatment but were evaluated in terms of 
con^arative survival on nonselective medium at the end of the 4-day 
mutation expression period ("expression" survival). Expression survival 
describes the actual number of viable cells treated with selective drug. 
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Figure 14. The induction of putative dibucaine-resistant 
clones from GF7 cells as a function of EMS concentration. 
Percent relative "expression" survival was determined by 
cloning a sample of EMS-treated cells, in nonselective medium 
after a 4-day expression period. This figure was expressed as 
a percentage of the cloning efficiency of non-EMS treated cells 
(control). The frequency of cells surviving dibucaine selection 
was calculated as: (total nimber of clones observed at EMS dose) 
%/ (tot^ calls treated with EMS dose X) (% "expression" survival at 
EMS dose X). 10^ cells were treated for each determination of 
mutagen response. 
Ill 
surviving dibuoaine selection divided by the number of cells surviving 
EMS treatment at the end of the expression period. The maj ority of 
clones surviving dibuoaine selection are expected to be drug resistant. 
For example, all 20 clones generated by the temperature-sensitive system 
(Figure 5) and the 20 clonal isolates examined after single-step selection 
at 37°C demonstrated some level of dibucaine resistance. It should be 
noted, however, that drug-sensitive cells may occasionally escape selective 
-7 
conditions at a very low frequency (5 x 10 ; Table 2) and probably 
give rise to a constant fraction of background number of clones surviving 
in the presence of 0.045 mM dibucaine for 48 hours. Nevertheless, this 
low level background cannot account for the observed increases in the 
number of clones presumably generated by treatment at higher EMS 
concentrations. 
As shown in Figure 14, at higher EMS concentrations, associated with 
a lower percentage of "expression" survival (400 ug/ml, 31% survival; 
600 ug/ml, 2% survival; 750 ug/ml, 0.1% survival), the number of putative 
variant clones increased progressively. This increase was 4-fold at 400 
ug/ml, 20-fold at 600 ug/ml, and 36-fold at 750 ug/ml of EMS, as compared 
with the nonmutagenized control population. At low mutagen doses (200 
ug/ml, where no significcint cell killing occurred, there was no increase 
over background numbers of surviving clones. The positive relationship 
between the number of variant clones produced and mutagen dose was 
reproducible in two other experiments. 
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Cell hybridizations 
Cell hybrids were obtained to determine whether the presumptive 
genetic lesion in two of the Dib variants was expressed as dominant or 
recessive* 
Preparation of hybrid and control cell lines The subline Dib -10 
mm  ^
(TK , HPRT ) was fused with the related dibucaine-sensitive line GP9 
(TK , HPRT ), and hybrids were selected in HAT medium (see Materials 
and Methods)• The frequency of hybrid clones in this e^qieriment was 
"5 9.2 X 10 , which was calculated as: (the total number of clones 
surviving HAT selection) / (10^ cells treated with PEG) (net viability 
after PEG treatment). When a non-PEG treated control mixture of 5 x 
10^ cells of each parent cell line (i.e., GF9 and Dib^-10) was cloned 
on HAT medium, no clones occurred. Therefore, the clones of the PEG-medi-
ated fusion of GP9 with Dib -10 are presumed to represent true genetic 
hybrids (Dib^/Dib®; Tk'^/Tk""; HPRT'^'/HPRT"). Of the 415 clones 
produced by the Dib -10 x GF9 cell fusion, ten hybrid clones were 
R -
picked randomly for further studies. Also, Dib -5 cells (Tk ; 
HPRT^) were fused with GF9 cells; this cell hybridization yielded five 
-5 
clones (hybrid frequency, 2.7 x 10 ). The hybrid pseudotetraploid 
(p4N) nature of these hybrid clones was confirmed by determining the 
relative modal cell size with a Coulter P64 particle size analyzer (true 
hybrids have an average modal size of approximately 1845u^ as opposed 
to lOSOu^ for each pseudodiploid parent) and by chromosome analysis 
(Figure 19). 
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For con^sarative purposes, it was also necessary to have both a pseudo-
tetraploid hybrid cell subline homozygous for the wild-type dibucaine-
sensitive (Dib®) allele(s) and a pseudotetraploid cell line homozygous 
for the dibucaine-resistant (Dib^) allele(s). The Dib® control hybrid 
was prepared by fusing GF7 wild-type cells with GF9 wild-type cells. These 
-5 R hybrids were observed at a frequency of 8 x 10 . A Dib -10 pseudo-
tetraploid subline was obtained by treating pseudodiploid Dib -10 variant 
cells with 1 ug/ml of cytochalasin D for 30 hours. Because cytochalasin D 
allows karyokinesis to continue normally while cytokinesis is inhibited 
(Goldman et al., 1975; Dickerman and Goldman, 1976), this 30-hour treatment 
produced 95% binucleates in the cell population. The induced pseudotetra­
ploid cells resumed normal division after removal of cytochalasin D. A 
pseudotetraploid clone was picked and designated Dib -10:p4N (Figure 19). 
p 
Response of hybrid lines and the Dib -10;p4N line to dibucaine 
The pseudotetraploid Dib® control hybrid (GF7 x GF9) proved to be more 
tolerant of the growth limiting-effects of dibucaine than either of the 
pseudodiploid Dib® parents, GF7 and GF9. As shown in Figure 15, the 
p4N Dib® hybrid cell population rapidly doubled (Td was approximately 
14 hours) in the presence of 0.025 mM and 0.030 mM dibucaine for 20 
hours. After this time, a Td of approximately 27 hours was maintained in 
these drug concentrations. In contrast, the growth of p2N Dib® cell 
populations was inhibited at 0.025 mM dibucaine and a rapid decline in 
cell number was observed at 0.03 mM drug. A concentration of 0.04 mM 
dibucaine was required to limit growth in the p4N Dib® control hybrid 
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Figure 15. Growth curves of pseudodiploid parental lines ( ) GF7, 
(——) GF9/ and their hybrid clone ( ). GP7 x GP9 in the presence of (•) 
0.025 mM dibucaine or (0) 0.03 mM dibucaine. Cell number was determined 
as in Figure 3. The population doubling times in the absence of drug 
were: GF7, 11 hours; GP9, 12 hours; GF7 x GF 9, IS hours. 
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chromosome ploldy or the greater cell size. The p4N Dib^ control 
hybrid bad a modal size of 1841a^/ whereas, the modal sizes of the p2N 
a 3 3 
Dib cell lines were lOlOu for GF7 and 1039u for GP9. Therefore, 
a dibacaine concentration of 0.04 mH rather than 0.025 mM was 
needed to demonstate a difference in drug sensitivity between the p4N cell 
hybrids of Dib -10 and the p4N dibacaine sensitive control hybrid. 
T> 
In the presence of 0.04 mM dibucaine, all ten Dib -10 x GP9 hybrid 
populations maintained exponential growth (Figure 16). After 16 to 26 
hours of dibacaine escposore/ these hybrid cell populations had doubled in 
cell number, and 3 days later, the populations had increased in total 
cell number from 2.5-fold to 5-fold. -In contrast, the Dib^ control 
hybrid population rapidly decreased in cell number in 0.04 znM dibucaine, 
and by 3 days, no viable cells were detected by trypan-blue exclusion. 
R 
The property of resistance contributed by Dib -10 is, therefore, 
dominant over dibucaine sensitivity. 
Although dibucaiine resistance has a dominant expression in the 
TS 
Dib -10 variant hybrids, the nature of the dominance could not be 
established in the experiment just described. Because cell size appears 
to determine the level of dibucadne tolerated by cells, the resistance 
displayed by the pseudodiploid Dib -10 variant cells (average modal 
cell size » 1069 u^) cannot be compared directly to that level of 
resistance exhibited by the pseudotetraploid Dib -10 x GF9 hybrids 
(average modal cell size ranged from 1812 to 1950 u^)« Therefore, to 
distinguish incooplete dominemce from conflate dominance, the appropriate 
R pseudotetraploid Dib -10 subpopulation, which displayed an average 
3 R 
























Figure 16. Growth response of the ten hybrids derived from Dib -10 
in the presence of 0.04 mM dibucadne. The control hybrid is illustrated by 
( A—A). Viable cell number was determined by the number of trypan blue-
excluding cells. The population doubling times under normal conditions (drug-
free mediun) ranged from 13 to 16 hours for cell hybrids of Dib^-10/ and was 
14 hours for the Dib® control hybrid. 
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Dib -10 X GF9 hybrids exhibited similar levels of growth in the presence 
R 
of 0.04 mM dibucaine (Figure 17). The Dib -10;p4N population doubled 
in size after 14 hours in drug medium, and after 3 days reached a cell 
density of 1.0 x 10^ cells/ml (a 2.5-fold increase in cell number). 
R 
Likewise, the ten Dib -10 x GF9 hybrid populations doubled in size 
after 16 hours to 26 hours and obtained cell densities that ranged from 
5 5 
approximately 1.0 x 10 cells/ml to 2.0 x 10 cells/ml after 3 days 
of drug treatment. Therefore, the putative Dib -10 allele may be 
completely dominant to its wild-type allele. Incomplete dominance would 
be indicated by an intermediate growth rate of the cell hybrids of 
Dib^-10 X GF9 when compared with that of the p4N Dib^ control hybrid 
population and the Dib^-10;p4N population. 
Intermediate levels of drug resistance in pseudotetraploid hybrids 
of p2N drug-resistant (mutant-type) cells and p2N drug-sensitive (wild-type) 
cells is a reflection of gene dosage effects at the gross phenotypic 
level. For example, Lobban and Siminovitch (1975) studied the effects of 
gene dosage on the expression of resistance to alpha-amanitin, a specific 
inhibitor of RNA polymerase II. They found that pseudotetraploid hybrids 
of CHO cells, whose genomes consisted of equal contributions of alpha-
amanitin-resistant cells and alpha-amanitin-sensitive wild-type cells, 
exhibited a level of alpha-amanitin resistance intermediate to that of 
the two parents. Cell hybrids which were pseudohexaploid and derived 1/3 
of their genome from the alpha-amanitin-resistant parent and 2/3 of their 
genome from the alpha-ama;aitin sensitive-parent, however, were found to 












Figure 17. Growth curves of hybrid lines (A, GP7 x GP9; Dib -5 x 
GF9; •, Dib^lO x GP9), (0), pseudotetraploid subpopulation of Dib^-10, 
and Dib^-variants (0, Dib^-10; Ct, Dib^S), in the presence of 0.04 inM 
dibucaine. Only one hybrid line of each type is depicted. The population 
doubling times under normal-growth condition {medium.: without, drug), were. 15 
hours for the Dib^ control hybrid, 16 hours for the hybrid of Dib^S, and 
Dib^lO, 17 hours for Dib^-10;p4N, 12.5 hours for Dib^S, and 13.5 hours, 
for Dib^lO. Viable cell number was determined as in Figure 3. 
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It should be noted that pseudodominance can result from the loss 
of chromosome(s) bearing the wild-type allele(s) contributed by the GF9 
parent. In this instance, a recessive genotype could be expressed as a 
dominant phenotype. Genetic analysis of intralineal hybrids in the 
strains GF9 and GF7 (15 generations after cloning) showed that there is 
a minimal early chromosome loss but that over a period of several months 
there is a low level of random chromosome loss at a rate of about 
5 X 10 per cell per generation (Stadler, unpublished; Iowa State 
University/ Department of Genetics). This rate of chromosome loss in 
intralineal hybrids is in the range of rates of segregation reported by 
other authors (Chasin, 1973). Because chromosome loss is infrequent/ it 
is unlikely that all ten Dib -10 x GF9 hybrids tested lost the same 
wild-type allele(s). The probably of this happening would be 9.76 x 
-64 4 10 
10 ( [1/40 X V5 X 10 ] ^"). 
Three of the five somatic cell hybrids dervived from the Dib -5 x 
GF9 hybridization were examined for dibucaine resistance. These hybrids 
did not acquire a resistant phenotype but died in the presence of 0.04 mM 
dibucaine like the Dib® control hybrid (Figure 18). Therefore/ the 
putative dibucaine allele of Dib -5 is expressed recessively. Neverthe­
less/ there exists the possibility of loss of chromosome(s) carrying the 











Figure 10. Growth response of the three hybrids (0—0, •—a , #—«) 
derived from Dib^S in the presence of 0,04 mM dibucaine at 37°C. The 
dibucaine-sensitive control hybrid GF7 x GF9 is depicted by (A—A) . Viable 
cell number was determined by the number of trypan blue-excluding cells. 
The growth rate of these cell lines in drug-free medium ranged from 14 to 
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Figure 19. Frequency of chromosome numbers in the parental cell lines, GF7 and GF9, Dib 
variants, derived hybrids, and Dib^lO:p^. 
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DISCUSSION 
This investigation showed that dibucaine can be used as a selective 
agent for obtaining somatic cell variants that are resistant to its 
cytotoxic effects. Dibucaine-resistant mouse lymphoma cells were re­
trieved from a wild-type population after EMS treatment and single-step 
selection. The dibucaine-resistant phenotype seems to be the result of 
gene mutation because of the observed phenotypic stability and the obr-
served increases in variant frequency when treated with increasing mutagen 
concentration. In addition, the variant phenotype was observed to be 
dominant in one variant subline (Dib^-10) but recessive in another variant 
subline (Dib -5). Dibucaine-resistant variants were found to be cross-
resistant to tetracaine, another local anesthetic. 
The Recovery of Dibucaiine-Resist ant Cells 
Traditionally, the most straightforward method for selecting drug-
resistant mutants is plating cells in the presence of cytotoxic drug 
concentrations (Thompson, 1979; Thompson and Baker, 1973). However, 
because initial attempts in this study to obtain variants by this method 
were unsuccessful, another single-step method that involved treating cells 
in suspension with a high concentration of dibucaine (0.045 mM) for a short 
period of time was used at 37°C. Also, a 39°C temperature-sensitive 
method was performed under identical selective conditions to obtain 
variants resistant to dibucaine. 
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The frequency of occurrence of 
dibacaine-surviving cells 
The mutation frequency represents the fraction of the total cell 
population expressing a certain mutant phenotype. Mutations can either 
occur spontaneously or be induced by mutagen treatment. The frequency 
of mutants induced by mutagen treatment is calculated on the basis of the 
number of cells surviving mutagen treatment at the end of the expression 
period; this number is determined by cloning mutagen-treated cells in 
nonselective medium (Friedrich and Coffino, 1977; Hsie et al., 1975). 
Mutation frequency is distinguished from mutation rate, which defines the 
average number of mutations to a particular mutant phenotype per cell per 
generation as determined by fluctuation analysis (Thompson and Baker, 1973; 
Baker et al., 1974;, Shapiro and Varshaver, 1977). 
The mutagen EMS was used to increase the frequency of putative 
mutants in the wild-type GF7 population. The frequency of EMS-induced 
R —3 
Dib variants in the single-step 37"C system was 4 x 10 , however, the 
frequency of Dib variants derived from the temperature-sensitive selection 
_5 
was much lower, 1.7 to 4.7 x 10 . This difference between variant fre­
quencies is not unexpected in these two systems because mutagen treat­
ment times varied by nine hours and population doubling times varied by 
approximately eight to ten hours during both mutagen treatment and 
expression in nonselective medium. The mutagen dose and the number of 
cell generations in nonselective medium prior to selection has been 
reported to affect the frequency of occurrence of a mutant phenotype 
(Cole and Artlett, 1976; Friedrich and Coffino, 1977; Hsie et al., 
1975). 
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The frequency of occurrence of the Dib variants is close to the 
range of mutation frequencies reported for other drug-resistant cells. 
For example, Friedrich and Coffino (1977) observed that the induction of 
resistance to dibutryl cyclic AMP occurred at a mutation frequency of 
8 X 10 ^ when mouse lymphoma cells were treated with 800 yg/ml EMS 
for 24 hours and then incubated in nonselective medium for eight days. 
Hsie and co-workers (1975) found that 800 yg/ml EMS and an ej^ression 
-3 
period of seven days resulted in a 2.7 x 10 mutation frequency at the 
hypoxanthine-guanine phosphoribosyl transferase (HPRT) X-linked locus in 
CHO cells. Because a single mutational event would be phenotypically 
ej^ressed on a monosomic gene, a higher mutation frequency is expected 
of a marker situated on the functionally monosomic X chromosome than for 
one located at a diploid autosomal-linked locus. 
Mutants have been reported to occur spontaneously in wild-type cell 
-7 -3 populations at frequencies ranging from approximately 10 to 10 (for 
references see Thompson and Baker, 1973). The spontaneous frequency of 
dibucaine-resistant cells was not determined in this investigation. In 
one experiment, however, ten clones survived selection from a non-
7 
mutagenized control population of 2 x 10 cells at 37°C (Table 2). 
Because all ten clonal isolates were found to be as drug-sensitive as 
wild-type GF7 cells, the spontaneous mutation frequency must be less 
than 5 X 10 If a single drug-resistant clone had occurred, the 
spontaneous mutation frequency in this instance would have been 5 x 10~®. 
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Growth of Variant Cells in the Presence 
of Dibucaine 
Resistance of cells to dibucaine was usually ^sessed in terms of the 
ability of the drug to alter the rate of cell population growth in 
suspension culture. This measurement reflects the growth rate of the 
majority of individual cells in the population, but does not express 
directly any phenotypic heterogeneity of the population, in other words, 
extraordinarily fast or slow growth exhibited by a small fraction of cells 
in the presence of the drug. Evaluating drug response by this method 
avoids the influences of cell density and cell stress effects encountered 
when cloning in soft agar medium. 
In initiail tests, variable levels of drug resistance as measured by 
growth rate were found both among the 20 clonal isolates obtained by 
temperature-sensitive selection and among the 20 isolates chosen randomly 
from the 415 clones derived from the single-step selection scheme at 
37°C. For example, 34 clonal isolates displayed population doubling 
times that varied over a range of 18 to 52 hours in the presence of 
0.025 mM dibucaine. The variant sublines Dib^-1, Dib^-5, Dib^-7, 
Dib -10 exhibited the best population growth and were studied further for 
their response to various dibucaine concentrations. Each variant subline 
was found to grow exponent!ally in dibucaine to 0.03 mM (Figure 9), 
and at 0.045 mM, only slight decreases (j< 4-fold) in cell number occurred. 
In contrast, the parent GF7 population declined rapidly when treated 
with 0.025 mM dibucaine. Four other variant sublines showed no growth 
at all in 0.025 mM dibucaine and two sublines declined in cell number. 
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although cell death was slower than in a culture of parent cells. A 
similar variable response between drug^resistant isolates has been 
observed with ouabain and colchicine resistance (Baker et al., 1974; Ling 
and Thompson, 1974). For example, the plating efficiencies of two 
ouabain-resistant clones of mouse L cells varied 68-fold in the presence 
of a cytotoxic concentration of ouabain (Baker et al., 1974). 
This variability may be due to alterations of unrelated gene locus 
or different DNA base sequence changes at the same gene loci. Obviously, 
if a variety of genotypes were affected, differences in phenotypic 
behavior could result among variant, sublines. Alternatively, the activity 
of a single gene product which may determine the level of drug resistance 
depends on the nature of the molecular alteration of the gene. As an 
example, a nonsense defect may result in a loss of production of the gene 
product and a missense defect may result in the formation of a struc­
turally altered, but partially functional gene product. 
Cloning measures directly the ability of the drug to suppress growth 
for each individual cell in a population, although it does not easily 
measure the effects of the drug on the rate of cell growth. In two cases, 
R R drug resistance was assayed by cloning variant cells of Dib -5 and Dib -10 
in different concentrations of dibucaine (Table 3). These variants 
exhibited cloning efficiencies greater than the wild-type cell line at 
dibucaine concentrations up to 0.015 mM. The growth of individual parent 
and variant cells, however, was completely suppressed at 0.02 mM drug. 
This is in contrast to growth in suspension culture at 0.02 mM dibucaine 
where both parent and variant cell populations showed an overall increase 
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in cell number, but at different rates. This difference may be a reflec­
tion of cell density effects on dibucaine cytotoxicity where cells are 
more sensitive to the cytotoxicity of dibucaine at lower cell densities 
than at higher cell densities. In these experiments cells were cloned at 
20 cells/ml (low cell density), while they were treated at 4 x 10^ cells/ml 
(high cell density) in suspension. Alternatively, the combination of 
dibucaine cytotoxicity and the physical stress of cloning in soft agar 
medium with a 10 to 14 day incubation could account for the diminished 
resistance observed when cloning in soft agar medium. 
Other investigators have reported dibucaine inhibition of membrane-
associated activity at various dibucaine levels. The minimum dibucaine 
concentration necessary to block the action potential of frog sciatic 
nerve is approximately 10-fold lower (0.005 mM') than the amount of 
dibucaine required to limit growth in the variants and 5-fold lower than 
the concentration which inhibits growth in the parental cells (Skou, 1954). 
Dibucaine concentrations which cause a 50% inhibition of Sendai virus-
induced fusion (0.045 mM; Poste and Reeve, 1972) and which block ion 
transport in erythrocytes (0.05 mM; Feinstein et al. , 1977) are roughly 
equivalent to the drug concentrations (0.025 to 0.03 mM) that permit 
growth of the Dib variants, while the levels of dibucaine required to 
reduce phagocytosis in macrophages by 50% (0.08 mM; Fogler et al., 1978), 
and viral budding in BHK cells by 90% (0.1 mM; Richardson and Vaince, 
1978a) are approximately 3-fold higher than those concentrations. Changes 
in topographical distribution of cell surface molecules in mouse spleen 
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cells are observed at 0.2 mM dibucaine, about 5-fold higher than what 
the Dib cells exhibit drug resistance (Poste et al. , 1975b). 
Genetic Origin of the Dibucaine-Resistant Phenotype 
To provide evidence that dibucaine resistance occurs as a result of 
gene mutation rather than epigenetic phenomena, several tests were con­
ducted. Phenotypic stability and the enhancement of the frequency of 
occurrence of the phenotype by mutagen treatment are considered to be 
indicative of an alteration in the genetic material (Siminovitch, 1976). 
Conversely, phenotypic variants that are the result of epigenetic modula­
tion are characterized by phenotypic instability, a high reversion 
frequency, and no enhancing effect of mutagens on their frequency of 
occurrence (Siminovitch, 1976r DeMars, 1974). 
The selected dibucaine-resistant phenotype is hereditarily stable 
in all four variant sublines (Dib -1, -5, -7, -10) studied. These variant 
sublines continued to express their drug-resistant phenotype after many 
months of continuous serial propagation in the absence of selective agent 
(Table 7). Although stability is consistent with attributing dibucaine 
resistance to a mutational origin, it does not conclusively prove a 
mutational origin (Thompson and Baker, 1973). Nevertheless, stable 
epigenetic events have been documented only in systems other than cultured 
mammalian cells, such ais tetrahymena (Nanney, 1968). 
The observed correlation between increasing mutagen concentration 
and increasing production of dibucaine-surviving clones strengthens the 
hypothesis of a genetic origin for dibucaine resistance. Other investiga­
tors have reported a positive correlation between mutation frequency and 
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mutagen dose in somatic cell mutants and this mutational change has been 
associated with an altered gene product (Friedrich and Coffino, 1977; 
Hsie et al., 1975). For example, Hsie and co-workers (1975) found that 
the occurrence of resistance to 6-thioguanine, which is due to the 
decreased activity of hypoxanthine-guanine phosphoribosyl transferase 
(HPRT), increased proportionately with increasing EMS concentrations. 
They observed that mutations of 6-thioguanine resistance in CHO cells 
was enhanced 8-fold by 200 pg/ml of EMS, 12-fold by 400 yg/ml of EMS, 
and 27-fold by 800 yg/ml of EMS. 
In this study a similar dosage pattern was observed. It was found 
that the occurrence of clones surviving dibucaine selection increased as 
EMS concentration increased. For example, the number of dibucaine-
resistant clones increased 4-fold over background at 400 yg/ml EMS, 20-
fold at 600 Vg/ml EMS, and 36-fold at 750 yg/ml EMS (Figure 14). The 
observed surviving clones are assumed to have some level of drug 
resistance. This drug-resistant expression is somewhat variable 
(Figure 5). It should be noted that treatment with 0.045 mM dibucaine 
for 48 hours may not kill all of the wild-type cells; the frequency of 
drug-sensitive cells which have escaped selection has been shown to be 
-7 
extremely low (5 x 10 ; Table 2). This frequency is, of course, constant 
and cannot account for the observed increase in the incidence of 
dibucaine-surviving clones over the wide range of EMS doses used. 
Therefore, the response to increasing mutagen concentration is inter­
preted to indicate that dibucaine resistance is the result of altera­
tions in the DNA induced by EMS (Drake, 1976) and not due to a selec­
tion artifact. 
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Clearly, evidence for a change in the structure of a gene product 
(e.g., protein) provides a strong case for ascribing a phenotypic 
variation to a gene mutation. The scope of this investigation did not 
include such studies. Nevertheless, mammalian cell mutants which have 
been shown to have a modification of a protein have been invariably 
shown to have a stable phenotype and a frequency of occurrence that can ? 
be increased by mutagen treatment (Chu and Mailing, 1968; Siminovitch, 
1976; Till et al., 1973). Thus, a stable variant phenotype whose 
occurrence can be enhanced by mutagen treatment, generally is the result 
of an altered gene product. 
The Dominance and Recessiveness of the Dibucaine-
Resistant Phenotype in Hybrid Cells 
Genetic analysis of mutant phenotypes by cell hybridization can 
offer insight into gene activity by investigating whether a gene is 
expressed dominantly or recessively. For example, drug-resistance is 
expressed dominantly when cell hybrids formed from drug-resistant 
(mutant-type) and drug-sensitive (wild-type) cells exhibit drug resistance 
to the same extent as the drug-resistant mutant. When dominance is 
incomplete, however, these hybrids display a level of resistance inter­
mediate between that of the drug-resistant mutant and drug-sensitive 
parent. A recessive mutation is characterized by drug sensitivity in 
the hybrids, which is like that of the parental (wild-type) cells. 
The presmed dibucaine-resistant gene marker of Dib -10 variant 
cells seems to be completely dominant to its wild-type allele(s) because 
R S 
ten pseudotetraploid cell hybrids of Dib -10 x Dib -GF9 were as drug 
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resistant as the dibucaine-resistant pseudotetraploid subpopulation of 
R 
Dib -10. For example, when grown in the presence of 0.04 mM dibucaine 
for 3 days, these cell hybrids increased approximately 2.5- to 5-fold 
in cell number. Similarly, the pseudotetraploid dibucaine-resistant 
population increased about 2.5-fold. A change in only one allele of 
the parent would be required for the expression of a dominant mutation. 
Interpretation of dominance relationships in cell hybridization 
studies is complex because the possibility that chromosome loss could 
result in the elimination of homologous wild-type allele(s), in other 
words, pseudodominance. In the case of pseudodominance, a recessive 
mutation would be expressed as a dominant phenotype. If, however, 
chromosome loss in the hybrids can be ruled out, the simplest explanation 
for complete dominance is that the observed phenotypic alteration may be 
the result of a mutation in a trans-acting regulatory gene (Davis and 
Adelberg, 1973). Gene regulatory mutants have been described in 
mammalian cell systems. For example, Kadouvi and co-workers (1978) 
provided evidence for a dominant trans-acting regulatory gene which 
reduces the activity of hypoxanthine-guanine phosphoribosyl transferase 
in mouse L cells. Also, Klebe and associates (1970) demonstrated by 
cell hybridization of mouse and human cells the existence of dominant 
trans-acting genes regulating the activity of esterase in human 
adenocarcinoma cells. 
Also, phenotypic dominance could occur as the result of inter­
actions among multiple identical subunits of a particular structure, 
such as a protein. As an example, a multimeric protein may be composed 
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of wild-type and mutant subunits. It is hypothesized that the presence 
of any proportion of the mutant subunits in the multimeric protein causes 
a decreased activity in this protein. Nevertheless, there will be some 
multimeric proteins composed of only wild-type subunits because mutant 
and wild-type subunits will combine at random. If, however, the multi­
meric protein is composed of a large number of subunits, for example, at 
least four subunits (tetramer), the majority of the wild-type subunits 
will be in a hybrid protein containing at least one mutant subunit. The 
ratio of wild-type tetramer proteins to hybrid tetramer protein con­
taining from one to four mutant subunits would be 1:16. It is assumed 
that this small fraction (1/16) of wild-type protein does not influence 
the overall phenotype. Thus, the mutation would appear as completely 
dominant. 
Evidence for this latter mechanism has not been provided using 
mammalian cells, but, there are data from other systems which supports 
this model. For example, in Neurospora, glutamic dehydrogenase isolated 
from heterokaryons formed between strains deficient in this enzyme and 
wild-type strains has been found to be reduced in activity (Fincham and 
Day, 1972). Also, in the lactose operon of Eschericia coli, dominant 
mutations have been found which are the result of an inactive repressor 
protein that is a tetrameric hybrid molecule composed of both wild-type 
and mutant subunits (Gilbert and Muller-Hill, 1970). 
Another way in which phenotypic dominance could arise is when a 
protein (or lipid) must be inserted into the plasma membrane after its 
biosynthesis in the cytoplasm. If the plasma membrane has a limited 
capacity for this protein and if the mutant protein is integrated more 
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efficiently than the wild-type protein, the plasma membrane could con­
tain predominantly mutant protein. Thus, in this case, dominance could 
be complete. There are no experimental data from other studies which 
support this mechanism. 
R R 
In contrast to Dib -10, the Dib -5 phenotype was recessive in cell 
hybrids. Three Dib -5 x Dib GP9 hybrids were found to be as sensitive 
C 
to 0.04 mM dibucaine as the Dib control hybrid (GF7 x GF9). In diploid 
cells, one might e:gect the expression of recessive mutations to be 
suppressed by the homologous wild-type allele(s). By standard mutational 
theory recessive phenotypes could be expressed after a single mutational 
event only if the recessive mutation was localized at a gene present on 
the X chromosome (functionally monosomic) , at a chromosomal locus where 
the alleles were originally present in the heterozygous condition, or 
at an autosomal gene in which a deletion of the homologous locus had 
occurred. There is evidence indicating that many genes in established 
cell lines exist in a monosomic or heterozygous state (Siminovitch, 
1976; DeMars, 1974; Morton et al., 1977). 
A recessive mutation can be interpreted as either an alteration in 
a regulatory gene or simply a change in a structural gene. It should be 
noted, however, that if all three Dib -5 x GP9 cell hybrids lost the 
p 
same chromosome bearing the dominant mutation contributed by Dib -5, 
a dominant genotype would be expressed as a recessive phenotype (i.e. , 
pseudorecessiveness). 
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Dibucaine Tolerance and Pseudotetraploidy 
The cell hybridizations that were conducted in this study revealed 
that wild-type pseudodiploid cell populations are more growth inhibited 
than wild-type pseudotetraploid cell populations at the same dibucaine 
concentration. For example, 0.025 mM dibucaine is cytotoxic for wild-
type pseudodiploid cells, whereas, wild-type pseudotetraploid cells will 
continue to multiply at a normal rate at this drug concentration 
(Figure 15). It is not known if the ability of pseudotetraploid cells 
to tolerate the cytotoxic effects of dibucaine is related to an increase 
in chromosome ploidy per se (i.e., gene dosage effects) or to the 
concomitant increase in cell size. 
This phenomenon has been observed in studies with other drugs. In 
studies of ouabain cytotoxicity, the ouabain concentration required to 
reduce the plating efficiency of pseudodiploid wild-type CHO cells 10-fold 
was approximately 0.04 mM. However, approximately 0.06 mM was needed to 
cause a similar 10-fold reduction in pseudotetraploid wild-type cells 
(Baker et al., 1974). Additionally, Yau and co-workers (1979) found 
that a pseudotetraploid subline derived from L5178y mouse lymphoma cells 
was more tolerant to the local anesthetics procaine, tetracaine, lido-
caine, and dibucaine than pseudodiploid parent cells. An increase in 
drug tolerance in pseudotetraploid cells is probably indicative of the 
number of drug-binding sites. 
Other Local Anesthetic-Resistant 
Variants and Mutants 
Recently, Yau and associates (1979) isolated cells resistant to the 
local anesthetic procaine using L5178Y, the same cell line that was 
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employed in this study. Nonmutagenized cells were grown at progressively 
higher concentrations of procaine until after several months the cell 
population was resistant to 1.5 mM procaine. This enrichment selection 
used to recover drug-resistant cell types is not an ideal technique for 
the genetic analysis of resulting cell variants because a number of 
genetic changes may have occurred to give rise to the observed variant 
phenotype. These authors speculated that the procaine-resistant pheno-
type originated by gene mutation. The evidence presented by these 
authors, however, is not entirely convincing. These resistant cells were 
observed to have a modal chromosome number of 75 and an average cell 
volume of 1084 that was similar to a naturally-occurring pseudo-
tetraploid cell line which had a modal chromosome number of 80 and a 
cell volume of 1121 The procaine-resistant cells isolated by this 
enrichment selection were approximately 4-fold more resistant to pro­
caine than wild-type pseudodiploid parent cells and slightly more 
resistant (2.5-fold) than naturally occurring pseudotetraploid cells, 
as determined by growth rate in suspension culture in the presence of 
procaine for three days. Nevertheless, it is difficult to distinguish 
drug tolerance due to an increase in cell size or gene dosage from drug 
resistance that might be the result of another process, such as gene 
mutation. Hence, it seems conceivable that the procaine-resistant cells 
isolated by these investigators may have arisen because of a growth 
advantage of a subpopulation pseudotetraploid cells over a population of 
pseudodiploid cells when cultured in selective medium containing 
procaine. In addition, the selected pseudotetraploid subpopulation 
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may be less affected than a naturally occurring pseudotetraploid popula­
tion by procaine because during enrichment selection a particular 
constitution of retained chromosomes was selected for within the pseudo­
tetraploid population. This constitution, which is not exactly the same 
as a karyotype for a naturally occurring pseudotetraploid population, 
may impart a greater drug tolerance to these selected p4N cells. 
True mutants that are resistant to the local anesthetic tetracaine 
have been obtained in bacteria. Dame and Shapiro (1976) used Escherichia 
coli to isolate after EMS mutagenesis and direct selection, mutant clones 
that are viable in 2.35 mM tetracaine. Tetracaine resistance (Tec ) 
was transduced into recipient strains. The Tec transductant strains 
displayed an abnormal colonial morphology and a slight prolongation of 
generation time. Biochemical analysis of the membranes of these mutants 
showed no alteration in phospholipid composition or fatty acid compo-
sition of lipids (Dame and Shapiro, 1978). When Tec cells were cultured 
in tetracaine no changes in phospholipid metabolism occurred, whereas, 
an increased amount of cardiolipin, and a reduction in phosphatidyl-
ethanolamine and phosphatidylglycerol were observed in wild-type cells. 
Dame and Shapiro (1978) found that the only disturbance in membrane 
composition was an increase in membrane protein content. 
Cross Resistance to a Related Local Anesthetic 
Cross resistance to related aromatic-amine local anesthetics, 
procaine, tetracaine, and benzocaine was assayed in the variant sublines. 
Dibucaine, tetracaine, and procaine are tertiary amines, while benzo-
caine is a primary amine (Table 4). The Dib isolates demonstrated a 
135 
limited pleiotrophy expressed primarily as resistance to the growth-
inhibiting effects of tetracaine with no cross resistance either to 
procaine or benzocaine (Figure 10). These data may be interpreted as 
indicating more than one specific molecular target site of anesthetic 
interaction at the drug concentration used; i.e., one interactive site 
for dibucaine and tetracaine and another one or more specific sites for 
procaine and benzocaine. Alternatively, one can envision a single 
molecular target with two separate reactive sites that are necessary 
for the binding of dibucaine and tetracaine. In this model the altera­
tion of only one of these reactive sites would prevent the binding of 
dibucaine and tetracaine, but the unaltered site would still be able to 
bind procaine and benzocaine. 
There is evidence, lending sTç>port to the former hypothesis, that 
suggests that procaine and benzocaine may be acting at sites different 
from tetracaine and dibucaiine. For example, Feinstein and co-workers 
(1977) found that tetracaine and dibucaine but not procaine interfered 
with sulfate transport, which is mediated by a specific transmembrane pro­
tein. This implies that procaine acts on the sulfate channel at a site 
that is not involved in ion transport, while tetracaine and dibucaine act 
at a site concerned with ion flux. In addition, benzocaine, which is 
neutral at physiological pH, has been shown to interact with membranes 
only in a nonspecific hydrophobic fashion rather than at a site-specific 
target (Boulanger et al., 1979). In contrast, charged anesthetics, like 
tetracaine and dibucaine, are believed to act at specific receptor 
sites by sm electrostatic or hydrogen bond interaction (Ueda et al., 
1976). 
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When determining cross resistance to tetracaine, procaine, and 
benzocaine, it was fovind that in terms of the drug concentrations 
required to stop cell growth (i.e., K = 0) in wild-type GF7 cells, these 
four local anesthetics were ordered as; procaine (6.1 mM) > benzocaine 
(2.6 mM) > tetracaine (0.22 mM) > dibucaine (0.023 mM). This is the 
inverse order of the lipid or membrane solubilities of these drugs; 
procaine < benzocaine < tetracaine < dibucaine (Seeman, 1972). Similarly, 
this correlation was observed with resistance to the growth limiting 
R 
effects of dibucaine and tetracaine. In other words, the Dib variants 
were resistant to higher concentrations of tetracaine (0.25 mM to 0.30 mM) 
than dibucaine (0.025 mM to 0.03 mM); dibucaine is more lipid or membrane 
soluble than tetracaine. Other authors have reported that the concen­
trations of these local anesthetics needed for the inhibition of nerve 
conduction, phagocytosis, cell spreading, capping, virus-induced fusion, 
also correlated with their lipophilia (Blaustein and Goldman, 1966a; 
Rabinovitch and DeStefano, 1976; Poste et al., 1975b; Poste and Reeve, 
1972; Fogler et al., 1978). 
The inverse relationship of membrane solubility and local anesthetic 
concentrations required to inhibit cell growth may imply that the cyto­
toxic effects of these drugs (procaine, dibucaine, tetracaine, benzo­
caine) are the result of their action on the plasma membrane. Moreover, 
because this relationship also was observed with drug resistance to 
tetracaine and dibucaine, the drug resistant phenotype possibly may 
originate at the level of the plasma membrane. 
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Membrane Behavior of the Dibucaine-Resistant 
Variant Phenotype 
Because dibucaine has been shown to alter membrane-dependent 
functions, such as fusion, capping, phagocytosis, exocytosis, and ion 
transport in mammalian cell lines (Poste and Reeve, 1972; Poste et al., 
1975b; Fogler et al., 1978; Peinstein et al., 1977), it was believed 
that the selected dibucaine-resistant phenotype might be associated with 
a defect in one or more of these membrane-dependent functions. This 
could occur if the altered structure responsible for dibucaine resistance 
was also involved in one of these membrane functions. Therefore, initial 
attempts to detect a defective membrane-function involved tests of plasma 
membrane fusion competence and capping of protein receptors. 
Dib^-5 was as fully capable of cell fusion as the parent cell line 
(Table 5). In contrast, the percentage of PEG-induced cell fusion of 
Dib -10 was significaintly lower than the parent cell line. It is not 
known if this reduced ability of these variant cells to fuse is simply 
a reflection of the population doubling time (Figure 11). If dibucaine 
resistance, however, is associated with a defect that is related to 
membrane fusion, the alterations of several membrane structures can be 
speculated. The possibility exists that there may be an alteration in 
the nature and quantity of membrane lipid or protein, alterations in 
membrane fluidity, or an alteration in calcium membrane-binding because 
all of these factors have been implicated in the mechanism of cell 
fusion (Lucy, 1975; Poste and Reeve, 1972; Poste and Allison, 1973). 
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The lateral movement of ConA receptors was only examined in one 
variant subline (Dib -10) and, in this case, was found to be similar 
to the parent cell line (Table 6). Therefore, in Dib -10 there is no 
apparent alteration in the lateral mobility of ConA receptors, a process 
that is dependent on membrane fluidity and a functional cytoskeletal 
system (Poste et al., 1975b; DePetris et al., 1975). 
Perspectives 
The principal findings presented in this study indicate that 
selected phenotypic resistance to dibucaine in mammalian cells may be 
the result of a gene mutation. The exact sequence of reactions that leads 
to the killing of GF7 cells by dibucaine and the nature of the alteration 
that renders these cells resistant to the cytotoxicity of dibucaine is 
unknown. Because dibucaine and other local anesthetics have been shown 
to alter the structure and function of the plasma membrane (Seeman, 
1972; Richards, 1978; Poste et al., 1975b; Rabinovitch and DeStefano, 
1976; Fogler et al., 1978), cytotoxicity may be the result of the action 
of this drug at the level of the plasma membrane. Thus, it is conceivable 
that resistance to dibucaine may be the result of an alteration within 
the membrane per se. 
A change in the specific binding of dibucaine at the cell surface 
may indicate an alteration at the level of the plasma membrane. Further 
biochemical studies can be performed to distinguish which membrane 
structure(s) are changed. Because it is known that dibucaine causes 
aberrations in the lipid phase of the plasma membrane (Seeman, 1972), 
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characterizations of the phospholipid composition may detect an altera­
tion in the type or quantity of membrane lipid. Also, the possibility 
exists that the type and quantity of membrane protein may be altered 
because local anesthetics can result in conformational chemges of protein 
(Ueda et al., 1976). Dame and Shapiro (1978) demonstrated that this was 
the site of alteration in their tetracaine-resistant bacterial mutants. 
Another possibility would be changes in calcium binding to the membrane 
because local anesthetics are known to displace and compete for membrane-
associated calcium binding sites (Blaustein and Goldman, 1966a,b). If this 
was found to be the case, then one could determine if calcium was being 
removed from membrane protein or lipid. 
While recent, research has elucidated the structure of the component 
lipids and proteins found in the plasma membrane, little is known about 
their functional-structural relationships. However, future studies of 
these dibucaine-resistant variants may reveal an aLLtered membrane 
function and structure. Once this is accomplished, information will 
be provided about one aspect of the relationship of plasma membrane 




A series of dibucaine-resistant variants (Dib ) of the mouse lymphoid 
cell line L5178Y were isolated after treatment with the mutagen ethyl 
methane sulfonate and exposure to a high concentration of the local anes-
thetic dibucaine (0.045 mM) for 48 hours. The Dib isolates demonstrate 
exponential growth in the presence of 0.025 mM to 0.030 mM dibucaine, drug 
concentrations that are toxic to the parent cell line. When cultured in 
the absence of the drug, the variants display a stable transmission of the 
dibucaine-resistant phenotype, and the frequency of Dib^ variants increases 
as the concentration of inducing mutagen is increased. These latter two 
findings suggest, but do not prove, that the dibucaine-resistant pheno­
type occurs because of gene mutation. All Dib^ isolates were found to be 
cross resistant to the growth-inhibiting effects of tetracaine, a second 
local anesthetic. However, in the presence of the local anesthetics 
procaine and benzocaine, the variants were as growth limited as the 
parental line. 
Chromosome number of cell size is an important consideration when 
evaluating the toxicity of this drug because normal pseudotetraploid cells 
are more tolerant to the toxic effects of dibucaine than are wild type 
pseudodiploid cell populations. Hybridization studies indicate that the 
dibucaine-resistant phenotype of one variant may be genetically recessive, 
and that of another variant line may be completely dominant rather than 
incompletely dominant when compared with the corresponding pseudotetraploid 
R 
variant control. Dib variants will be important in future studies of 
the mechanism of local anesthetic action on cell membranes. 
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